IDEAS home Printed from https://ideas.repec.org/e/c/pso62.html
   My authors  Follow this author

Neeraj Sood

Citations

Many of the citations below have been collected in an experimental project, CitEc, where a more detailed citation analysis can be found. These are citations from works listed in RePEc that could be analyzed mechanically. So far, only a minority of all works could be analyzed. See under "Corrections" how you can help improve the citation analysis.

Blog mentions

As found by EconAcademics.org, the blog aggregator for Economics research:
  1. Amelia M. Haviland & Matthew D. Eisenberg & Ateev Mehrotra & Peter J. Huckfeldt & Neeraj Sood, 2015. "Do “Consumer-Directed” Health Plans Bend the Cost Curve Over Time?," NBER Working Papers 21031, National Bureau of Economic Research, Inc.

    Mentioned in:

    1. Thesis Thursday: Sarah Zheng
      by Chris Sampson in The Academic Health Economists' Blog on 2018-03-15 07:00:19
  2. Neeraj Sood & Karen Mulligan & Kimberly Zhong, 2021. "Do companies in the pharmaceutical supply chain earn excess returns?," International Journal of Health Economics and Management, Springer, vol. 21(1), pages 99-114, March.

    Mentioned in:

    1. Chris Sampson’s journal round-up for 22nd March 2021
      by Chris Sampson in The Academic Health Economists' Blog on 2021-03-22 12:00:01

RePEc Biblio mentions

As found on the RePEc Biblio, the curated bibliography of Economics:
  1. Jonathan H. Cantor & Neeraj Sood & Dena Bravata & Megan Pera & Christopher M. Whaley, 2020. "The Impact of the COVID-19 Pandemic and Policy Response on Health Care Utilization: Evidence from County-level Medical Claims and Cellphone data," NBER Working Papers 28131, National Bureau of Economic Research, Inc.

    Mentioned in:

    1. > Economics of Welfare > Health Economics > Economics of Pandemics > Specific pandemics > Covid-19 > Health > Allocation and rationing

Working papers

  1. Virat Agrawal & Neeraj Sood & Christopher M. Whaley, 2022. "The Ex-Ante Moral Hazard Effects of COVID-19 Vaccines," NBER Working Papers 30602, National Bureau of Economic Research, Inc.

    Cited by:

    1. Smart, Shanike J. & Polachek, Solomon, 2024. "COVID-19 Vaccine and Risk-Taking," IZA Discussion Papers 16707, Institute of Labor Economics (IZA).
    2. Aslim, Erkmen Giray & Fu, Wei & Tekin, Erdal & You, Shijun, 2023. "From Syringes to Dishes: Improving Food Security through Vaccination," IZA Discussion Papers 16009, Institute of Labor Economics (IZA).
    3. Robert J. Barro, 2022. "Vaccination Rates and COVID Outcomes across U.S. States," NBER Working Papers 29884, National Bureau of Economic Research, Inc.
    4. Virat Agrawal & Neeraj Sood & Christopher M. Whaley, 2023. "The Impact of the Global COVID-19 Vaccination Campaign on All-Cause Mortality," NBER Working Papers 31812, National Bureau of Economic Research, Inc.

  2. Virat Agrawal & Jonathan H. Cantor & Neeraj Sood & Christopher M. Whaley, 2021. "The Impact of the COVID-19 Vaccine Distribution on Mental Health Outcomes," NBER Working Papers 29593, National Bureau of Economic Research, Inc.

    Cited by:

    1. Erkmen G. Aslim & Wei Fu & Chia-Lun Liu & Erdal Tekin, 2022. "Vaccination Policy, Delayed Care, and Health Expenditures," NBER Working Papers 30139, National Bureau of Economic Research, Inc.
    2. Belmonte, A & Pickard, H, 2022. "Safe at Last? LATE Effects of a Mass Immunization Campaign on Households’ Economic Insecurity," CAGE Online Working Paper Series 604, Competitive Advantage in the Global Economy (CAGE).
    3. Emilio Depetris-Chauvin & Felipe González, 2023. "The Political Consequences of Vaccines: Quasi-experimental Evidence from Eligibility Rules," Documentos de Trabajo 572, Instituto de Economia. Pontificia Universidad Católica de Chile..
    4. Ren, He & Zheng, Yi, 2023. "COVID-19 vaccination and household savings: An economic recovery channel," Finance Research Letters, Elsevier, vol. 54(C).
    5. Agarwal, Vikas & Jiang, Wei & Luo, Yuchen & Zou, Hong, 2023. "The real effect of sociopolitical racial animus: Mutual fund manager performance during the AAPI Hate," CFR Working Papers 23-05, University of Cologne, Centre for Financial Research (CFR).
    6. , 2023. "The Political Consequences of Vaccines: Quasi-experimental Evidence from Eligibility Rules," Working Papers 953, Queen Mary University of London, School of Economics and Finance.
    7. Virat Agrawal & Neeraj Sood & Christopher M. Whaley, 2023. "The Impact of the Global COVID-19 Vaccination Campaign on All-Cause Mortality," NBER Working Papers 31812, National Bureau of Economic Research, Inc.
    8. Dominika Ochnik & Aleksandra M. Rogowska & Joy Benatov & Ana Arzenšek, 2022. "Adaptation and Preliminary Validation of the Fear of Coronavirus Vaccination Scale in the Prospective Study among a Representative Sample of Polish, Israeli, Slovenian, and German Adults during the CO," IJERPH, MDPI, vol. 19(18), pages 1-21, September.

  3. Virat Agrawal & Jonathan H. Cantor & Neeraj Sood & Christopher M. Whaley, 2021. "The Impact of the COVID-19 Pandemic and Policy Responses on Excess Mortality," NBER Working Papers 28930, National Bureau of Economic Research, Inc.

    Cited by:

    1. Matthew Owens & Ellen Townsend & Eleanor Hall & Tanisha Bhatia & Rosie Fitzgibbon & Francesca Miller-Lakin, 2022. "Mental Health and Wellbeing in Young People in the UK during Lockdown (COVID-19)," IJERPH, MDPI, vol. 19(3), pages 1-15, January.
    2. John Gibson, 2021. "Jabbing the Economy Back to Life?," Working Papers in Economics 21/11, University of Waikato.
    3. Chang-Lan Xia & An-Pin Wei & Yu-Ting Huang, 2022. "The COVID-19 Lockdown and Mental Wellbeing of Females in China," IJERPH, MDPI, vol. 19(9), pages 1-19, April.
    4. Holzer, Harry J. & Hubbard, Glenn & Strain, Michael R., 2021. "Did Pandemic Unemployment Benefits Reduce Employment? Evidence from Early State-Level Expirations in June 2021," IZA Discussion Papers 14927, Institute of Labor Economics (IZA).

  4. Dena Bravata & Jonathan H. Cantor & Neeraj Sood & Christopher M. Whaley, 2021. "Back to School: The Effect of School Visits During COVID-19 on COVID-19 Transmission," NBER Working Papers 28645, National Bureau of Economic Research, Inc.

    Cited by:

    1. Kurmann, Andre & Lalé, Etienne, 2022. "School Closures and Effective In-Person Learning during COVID-19: When, Where, and for Whom," IZA Discussion Papers 14984, Institute of Labor Economics (IZA).
    2. Rufrancos, Héctor & Moro, Mirko & Moore, Eva, 2021. "The impact of University reopenings on COVID-19 cases in Scotland," GLO Discussion Paper Series 868, Global Labor Organization (GLO).
    3. Nicola Fuchs-Schündeln & Dirk Krueger & André Kurmann & Étienne Lalé & Alexander Ludwig & Irina Popova, 2021. "The fiscal and welfare effects of policy responses to the Covid-19 school closures," CIRANO Working Papers 2021s-40, CIRANO.
    4. Svaleryd, Helena & Vlachos, Jonas, 2022. "COVID-19 and School Closures," GLO Discussion Paper Series 1008, Global Labor Organization (GLO).
    5. Koppa, Vijetha & West, Jeremy, 2021. "School Reopenings, COVID-19, and Employment," Santa Cruz Department of Economics, Working Paper Series qt07w4z6vb, Department of Economics, UC Santa Cruz.
    6. Virat Agrawal & Jonathan H. Cantor & Neeraj Sood & Christopher M. Whaley, 2021. "The Impact of the COVID-19 Vaccine Distribution on Mental Health Outcomes," NBER Working Papers 29593, National Bureau of Economic Research, Inc.
    7. Kairon Shayne D. Garcia & Benjamin W. Cowan, 2022. "The Impact of U.S. School Closures on Labor Market Outcomes during the COVID-19 Pandemic," NBER Working Papers 29641, National Bureau of Economic Research, Inc.
    8. Benjamin Hansen & Joseph J. Sabia & Jessamyn Schaller, 2022. "Schools, Job Flexibility, and Married Women's Labor Supply," NBER Working Papers 29660, National Bureau of Economic Research, Inc.
    9. Lattanzio, Salvatore, 2024. "Schools and the transmission of Sars-Cov-2: Evidence from Italy," Economics & Human Biology, Elsevier, vol. 52(C).
    10. Thomas Dee & Elizabeth Huffaker & Cheryl Phillips & Eric Sagara, 2021. "The Revealed Preferences for School Reopening: Evidence from Public-School Disenrollment," NBER Working Papers 29156, National Bureau of Economic Research, Inc.
    11. Benjamin Hansen & Joseph J. Sabia & Jessamyn Schaller, 2022. "In-Person Schooling and Youth Suicide: Evidence from School Calendars and Pandemic School Closures," NBER Working Papers 30795, National Bureau of Economic Research, Inc.

  5. Jonathan H. Cantor & Neeraj Sood & Dena Bravata & Megan Pera & Christopher M. Whaley, 2020. "The Impact of the COVID-19 Pandemic and Policy Response on Health Care Utilization: Evidence from County-level Medical Claims and Cellphone data," NBER Working Papers 28131, National Bureau of Economic Research, Inc.

    Cited by:

    1. Fu, Hongqiao & Cheng, Terence C. & Zhan, Jiajia & Xu, Duo & Yip, Winnie, 2024. "Dynamic effects of the COVID-19 pandemic on the demand for telemedicine services: Evidence from China," Journal of Economic Behavior & Organization, Elsevier, vol. 220(C), pages 531-557.
    2. Péter Elek & Anikó Bíró & Petra Fadgyas‐Freyler, 2021. "Income gradient of pharmaceutical panic buying at the outbreak of the COVID‐19 pandemic," Health Economics, John Wiley & Sons, Ltd., vol. 30(9), pages 2312-2320, September.
    3. Erkmen G. Aslim & Wei Fu & Chia-Lun Liu & Erdal Tekin, 2022. "Vaccination Policy, Delayed Care, and Health Expenditures," NBER Working Papers 30139, National Bureau of Economic Research, Inc.
    4. Virat Agrawal & Jonathan H. Cantor & Neeraj Sood & Christopher M. Whaley, 2021. "The Impact of the COVID-19 Pandemic and Policy Responses on Excess Mortality," NBER Working Papers 28930, National Bureau of Economic Research, Inc.
    5. Christopher J. Cronin & William N. Evans, 2020. "Nursing Home Quality, COVID-19 Deaths, and Excess Mortality," NBER Working Papers 28012, National Bureau of Economic Research, Inc.
    6. Dena Bravata & Jonathan H. Cantor & Neeraj Sood & Christopher M. Whaley, 2021. "Back to School: The Effect of School Visits During COVID-19 on COVID-19 Transmission," NBER Working Papers 28645, National Bureau of Economic Research, Inc.
    7. Wolfgang Frimmel & Gerald J. Pruckner, 2024. "The COVID-19 pandemic and health care utilization: Evidence from Austrian register data," Economics working papers 2024-03, Department of Economics, Johannes Kepler University Linz, Austria.
    8. Ge Bai & Daniel Jiménez & Phillip Phan & Luis E. Quintero & Alessandro Rebucci & Xian Sun, 2021. "The Financial Fragility of For-profit Hospitals: Evidence from the COVID-19 Pandemic," NBER Working Papers 29388, National Bureau of Economic Research, Inc.
    9. Anneliese N. Luck & Irma T. Elo & Samuel H. Preston & Eugenio Paglino & Katherine Hempstead & Andrew C. Stokes, 2023. "COVID-19 and All-Cause Mortality by Race, Ethnicity, and Age Across Five Periods of the Pandemic in the United States," Population Research and Policy Review, Springer;Southern Demographic Association (SDA), vol. 42(4), pages 1-29, August.
    10. Feng Huang & Hong Liu, 2023. "The impact of the COVID‐19 pandemic and related policy responses on non‐COVID‐19 healthcare utilization in China," Health Economics, John Wiley & Sons, Ltd., vol. 32(3), pages 620-638, March.
    11. Chen, Zhuo & Li, Pengfei & Liao, Li & Liu, Lu & Wang, Zhengwei, 2024. "Assessing and addressing the coronavirus-induced economic crisis: Evidence from 1.5 billion sales invoices," China Economic Review, Elsevier, vol. 85(C).
    12. Lauren Gilbert & Susan Parker & Lauren Schechter, 2024. "The impact of the COVID-19 pandemic on treatment for domestic violence injuries: evidence from medical claims," Review of Economics of the Household, Springer, vol. 22(2), pages 535-562, June.
    13. Monteic A. Sizer & Dependra Bhatta & Binod Acharya & Krishna P. Paudel, 2022. "Determinants of Telehealth Service Use among Mental Health Patients: A Case of Rural Louisiana," IJERPH, MDPI, vol. 19(11), pages 1-11, June.
    14. Bryan C. McCannon & Mark Wilson, 2023. "Mask Mandates Increased COVID-19 Deaths in Kansas," Journal of Private Enterprise, The Association of Private Enterprise Education, vol. 38(Winter 20), pages 29-54.
    15. Shooshan Danagoulian & Thomas A. Wilk, 2022. "Locking out prevention: Dental care in the midst of a pandemic," Health Economics, John Wiley & Sons, Ltd., vol. 31(9), pages 1973-1992, September.
    16. Yu shin Park & Soo Young Kim & Eun-Cheol Park & Sung-In Jang, 2022. "Screening for Diabetes Complications during the COVID-19 Outbreak in South Korea," IJERPH, MDPI, vol. 19(9), pages 1-12, April.

  6. Zachary Wagner & Somalee Banerjee & Manoj Mohanan & Neeraj Sood, 2019. "Does The Market Reward Quality?: Evidence from India," NBER Working Papers 26460, National Bureau of Economic Research, Inc.

    Cited by:

    1. Kai Shen Lim & Wei Aun Yap & Winnie Yip, 2022. "Consumer choice and public‐private providers: The role of perceived prices," Health Economics, John Wiley & Sons, Ltd., vol. 31(9), pages 1898-1925, September.
    2. He, Daixin & Lu, Fangwen & Yang, Jianan, 2023. "Impact of self- or social-regarding health messages: Experimental evidence based on antibiotics purchases," Journal of Development Economics, Elsevier, vol. 163(C).

  7. Kayleigh Barnes & Arnab Mukherji & Patrick Mullen & Neeraj Sood, 2016. "Financial Risk Protection from Social Health Insurance," NBER Working Papers 22620, National Bureau of Economic Research, Inc.

    Cited by:

    1. O'Donnell, Owen, 2024. "Health and health system effects on poverty: A narrative review of global evidence," Health Policy, Elsevier, vol. 142(C).
    2. Phuong Huu Khiem & Yu-Chen Kuo, 2022. "Health insurance reform impact on children’s educational attainment: evidence from Vietnam," Review of Economics of the Household, Springer, vol. 20(4), pages 1255-1285, December.
    3. Samuel Ampaw & Simon Appleton & Xuyan Lou, 2020. "Heterogeneous effect of health insurance on financial risk: Evidence from two successive surveys in Ghana," Discussion Papers 2020-04, University of Nottingham, CREDIT.
    4. Owen (O.A.) O'Donnell, 2019. "Financial Protection Against Medical Expense," Tinbergen Institute Discussion Papers 19-010/V, Tinbergen Institute.
    5. Xiaojun Lu & Qun Wang & Daishuang Wei, 2020. "Do Health Insurance Schemes Heterogeneously Affect Income and Income Distribution? Evidence from Chinese Agricultural Migrants Survey," IJERPH, MDPI, vol. 17(9), pages 1-12, April.
    6. Kartashova Olga Ivanovna & Molchanova Olga Vladimirovna & Axana Turgaeva, 2018. "Insurance Risks Management Methodology," JRFM, MDPI, vol. 11(4), pages 1-15, October.
    7. Aurélien Baillon & Aleli Kraft & Owen O'Donnell & Kim van Wilgenburg, 2019. "A behavioral decomposition of willingness to pay for health insurance," Tinbergen Institute Discussion Papers 19-077/I, Tinbergen Institute.
    8. Deo, Sarang & Tyagi, Hanu & Chatterjee, Chirantan & Molakapuri, Himasagar, 2020. "Did India's price control policy for coronary stents create unintended consequences?," Social Science & Medicine, Elsevier, vol. 246(C).
    9. Chatterjee, Chirantan & Joshi, Radhika & Sood, Neeraj & Boregowda, P., 2018. "Government health insurance and spatial peer effects: New evidence from India," Social Science & Medicine, Elsevier, vol. 196(C), pages 131-141.
    10. Chen, Yi & Shi, Julie & Zhuang, Castiel Chen, 2019. "Income-dependent impacts of health insurance on medical expenditures: Theory and evidence from China," China Economic Review, Elsevier, vol. 53(C), pages 290-310.

  8. Abby Alpert & Darius Lakdawalla & Neeraj Sood, 2015. "Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D," NBER Working Papers 21714, National Bureau of Economic Research, Inc.

    Cited by:

    1. Fabian Duarte & Srikanth Kadiyala & Samuel H. Masters & David Powell, 2017. "The Effect of the 2009 Influenza Pandemic on Absence from Work," Working Papers WR-1176, RAND Corporation.
    2. Suppliet, Moritz, 2017. "Umbrella Branding in Pharmaceutical Markets," Discussion Paper 2017-034, Tilburg University, Tilburg Law and Economic Center.
    3. Rosanna Smart & David Powell & Rosalie Liccardo Pacula & Evan D. Peet & Rahi Abouk & Corey S. Davis, 2023. "Investigating the Complexity of Naloxone Distribution: Which Policies Matter for Pharmacies and Potential Recipients," NBER Working Papers 31142, National Bureau of Economic Research, Inc.
    4. Janssen, Aljoscha & Zhang, Xuan, 2020. "Retail Pharmacies and Drug Diversion during the Opioid Epidemic," Working Paper Series 1373, Research Institute of Industrial Economics.
    5. Matthew T. Knowles, 2022. "How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1649-1675, August.
    6. Eisenberg, Matthew D. & Avery, Rosemary J. & Cantor, Jonathan H., 2017. "Vitamin panacea: Is advertising fueling demand for products with uncertain scientific benefit?," Journal of Health Economics, Elsevier, vol. 55(C), pages 30-44.
    7. Powell, David & Pacula, Rosalie Liccardo & Taylor, Erin, 2020. "How increasing medical access to opioids contributes to the opioid epidemic: Evidence from Medicare Part D," Journal of Health Economics, Elsevier, vol. 71(C).
    8. Robert Nathenson & Michael R. Richards, 2018. "Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws," International Journal of Health Economics and Management, Springer, vol. 18(3), pages 321-336, September.
    9. Kelli Marquardt & Conor Ryan, 2023. "The Role of Information in Pharmaceutical Advertising: Theory and Evidence," Working Paper Series WP 2023-40, Federal Reserve Bank of Chicago.

  9. Amelia M. Haviland & Matthew D. Eisenberg & Ateev Mehrotra & Peter J. Huckfeldt & Neeraj Sood, 2015. "Do “Consumer-Directed” Health Plans Bend the Cost Curve Over Time?," NBER Working Papers 21031, National Bureau of Economic Research, Inc.

    Cited by:

    1. Brot-Goldberg, Zarek C. & Chandra, Amitabh & Handel, Benjamin R. & Kolstad, Jonathan T., 2015. "What Does a Deductible Do? The Impact of Cost-Sharing on Health Care Prices, Quantities, and Spending Dynamics," Working Paper Series 15-060, Harvard University, John F. Kennedy School of Government.
    2. Ackley, Calvin A., 2022. "Tiered cost sharing and health care demand," Journal of Health Economics, Elsevier, vol. 85(C).
    3. Eisenberg, Matthew D. & Haviland, Amelia M. & Mehrotra, Ateev & Huckfeldt, Peter J. & Sood, Neeraj, 2017. "The long term effects of “Consumer-Directed” health plans on preventive care use," Journal of Health Economics, Elsevier, vol. 55(C), pages 61-75.
    4. Gruber, Jonathan & Maclean, J. Catherine & Wright, Bill & Wilkinson, Eric & Volpp, Kevin G., 2017. "The Impact of Increased Cost-Sharing on Utilization of Low Value Services: Evidence from the State of Oregon," IZA Discussion Papers 10477, Institute of Labor Economics (IZA).
    5. Rabideau, Brendan & Eisenberg, Matthew D. & Reid, Rachel & Sood, Neeraj, 2021. "Effects of employer-offered high-deductible plans on low-value spending in the privately insured population," Journal of Health Economics, Elsevier, vol. 76(C).
    6. Stefan Pichler & Jan Ruffner, 2016. "Does it really make a difference? Health care utilization with two high deductible health care plans," KOF Working papers 16-404, KOF Swiss Economic Institute, ETH Zurich.
    7. Whaley, Christopher M. & Brown, Timothy T., 2018. "Firm responses to targeted consumer incentives: Evidence from reference pricing for surgical services," Journal of Health Economics, Elsevier, vol. 61(C), pages 111-133.
    8. Chenyuan Liu & Justin R. Sydnor, 2018. "Dominated Options in Health-Insurance Plans," NBER Working Papers 24392, National Bureau of Economic Research, Inc.
    9. Christopher Whaley & Timothy Brown & James Robinson, 2019. "Consumer Responses to Price Transparency Alone versus Price Transparency Combined with Reference Pricing," American Journal of Health Economics, MIT Press, vol. 5(2), pages 227-249, Spring.
    10. Jonathan Gruber & Johanna Catherine Maclean & Bill Wright & Eric Wilkinson & Kevin G. Volpp, 2020. "The effect of increased cost‐sharing on low‐value service use," Health Economics, John Wiley & Sons, Ltd., vol. 29(10), pages 1180-1201, October.
    11. Molly Frean & Mark Pauly, 2018. "Does High Cost-Sharing Slow the Long-term Growth Rate of Health Spending? Evidence from the States," NBER Working Papers 25156, National Bureau of Economic Research, Inc.

  10. Peter J. Huckfeldt & Amelia Haviland & Ateev Mehrotra & Zachary Wagner & Neeraj Sood, 2015. "Patient Responses to Incentives in Consumer-directed Health Plans: Evidence from Pharmaceuticals," NBER Working Papers 20927, National Bureau of Economic Research, Inc.

    Cited by:

    1. Amelia M. Haviland & Matthew D. Eisenberg & Ateev Mehrotra & Peter J. Huckfeldt & Neeraj Sood, 2015. "Do “Consumer-Directed” Health Plans Bend the Cost Curve Over Time?," NBER Working Papers 21031, National Bureau of Economic Research, Inc.
    2. Ackley, Calvin A., 2022. "Tiered cost sharing and health care demand," Journal of Health Economics, Elsevier, vol. 85(C).
    3. Whaley, Christopher M., 2019. "Provider responses to online price transparency," Journal of Health Economics, Elsevier, vol. 66(C), pages 241-259.
    4. Eisenberg, Matthew D. & Haviland, Amelia M. & Mehrotra, Ateev & Huckfeldt, Peter J. & Sood, Neeraj, 2017. "The long term effects of “Consumer-Directed” health plans on preventive care use," Journal of Health Economics, Elsevier, vol. 55(C), pages 61-75.
    5. Gruber, Jonathan & Maclean, J. Catherine & Wright, Bill & Wilkinson, Eric & Volpp, Kevin G., 2017. "The Impact of Increased Cost-Sharing on Utilization of Low Value Services: Evidence from the State of Oregon," IZA Discussion Papers 10477, Institute of Labor Economics (IZA).
    6. Jonathan Gruber & Johanna Catherine Maclean & Bill Wright & Eric Wilkinson & Kevin G. Volpp, 2020. "The effect of increased cost‐sharing on low‐value service use," Health Economics, John Wiley & Sons, Ltd., vol. 29(10), pages 1180-1201, October.
    7. Salvi, Irene & Cordier, Johannes & Kuklinski, David & Vogel, Justus & Geissler, Alexander, 2023. "Price sensitivity and demand for healthcare services: Investigating demand-side financial incentives using anonymised claims data from Switzerland," Working Paper Series in Health Economics, Management and Policy 2023-06, University of St.Gallen, School of Medicine, Chair of Health Economics, Policy and Management.

  11. Neeraj Sood & Abby Alpert & Kayleigh Barnes & Peter Huckfeldt & Jose Escarce, 2015. "Effects of Payment Reform in More versus Less Competitive Markets," NBER Working Papers 21654, National Bureau of Economic Research, Inc.

    Cited by:

    1. Daifeng He & Peter McHenry & Jennifer M. Mellor, 2020. "Do financial incentives matter? Effects of Medicare price shocks on skilled nursing facility care," Health Economics, John Wiley & Sons, Ltd., vol. 29(6), pages 655-670, June.

  12. Elizabeth Bodine-Baron & Sarah Nowak & Raffaello Varadavas & Neeraj Sood, 2013. "Conforming and Non-conforming Peer Effects in Vaccination Decisions," NBER Working Papers 19528, National Bureau of Economic Research, Inc.

    Cited by:

    1. RyokoSato & Yoshito Takasaki, 2016. "Peer Effects on Vaccination: Experimental Evidence from Rural Nigeria," CIRJE F-Series CIRJE-F-1002, CIRJE, Faculty of Economics, University of Tokyo.
    2. Ginger Zhe Jin & Thomas G. Koch, 2018. "Learning by Suffering? Patterns in Flu Shot Take-up," NBER Working Papers 25272, National Bureau of Economic Research, Inc.
    3. Guo, Feiyu & Cao, Erbao, 2021. "Can reference points explain vaccine hesitancy? A new perspective on their formation and updating," Omega, Elsevier, vol. 99(C).
    4. Chevalier, Judith A. & Schwartz, Jason L. & Su, Yihua & Williams, Kevin R., 2022. "JUE Insight: Distributional Impacts of Retail Vaccine Availability," Journal of Urban Economics, Elsevier, vol. 127(C).
    5. Thayer Alshaabi & David R Dewhurst & James P Bagrow & Peter S Dodds & Christopher M Danforth, 2021. "The sociospatial factors of death: Analyzing effects of geospatially-distributed variables in a Bayesian mortality model for Hong Kong," PLOS ONE, Public Library of Science, vol. 16(3), pages 1-20, March.
    6. Chatterjee, Chirantan & Joshi, Radhika & Sood, Neeraj & Boregowda, P., 2018. "Government health insurance and spatial peer effects: New evidence from India," Social Science & Medicine, Elsevier, vol. 196(C), pages 131-141.

  13. John A. Romley & Neeraj Sood, 2013. "Identifying the Health Production Function: The Case of Hospitals," NBER Working Papers 19490, National Bureau of Economic Research, Inc.

    Cited by:

    1. Raquel Fonseca & François Langot & Pierre-Carl Michaud & Thepthida Sopraseuth, 2020. "Understanding Cross-Country Differences in Health Status and Expenditures," CIRANO Working Papers 2020s-16, CIRANO.
    2. Kleiner, Samuel A., 2019. "Hospital treatment and patient outcomes: Evidence from capacity constraints," Journal of Public Economics, Elsevier, vol. 175(C), pages 94-118.
    3. André Madeira & Victor Moutinho & José Alberto Fuinhas, 2021. "Does waiting times decrease or increase operational costs in short and long-term? Evidence from Portuguese public hospitals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(8), pages 1195-1216, November.
    4. Ketcham, Jonathan & Kuminoff, Nicolai & Saha, Nirman, 2023. "Valuing Statistical Life Using Seniors' Medical Spending," RFF Working Paper Series 23-16, Resources for the Future.

  14. Huckfeldt, Peter J. & Sood, Neeraj & Escarce, Jose J. & Grabowski, David C. & Newhouse, Joseph P., 2012. "Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems," Working Paper Series rwp12-007, Harvard University, John F. Kennedy School of Government.

    Cited by:

    1. Neeraj Sood & Abby Alpert & Kayleigh Barnes & Peter Huckfeldt & Jose Escarce, 2015. "Effects of Payment Reform in More versus Less Competitive Markets," NBER Working Papers 21654, National Bureau of Economic Research, Inc.
    2. Daifeng He & Peter McHenry & Jennifer M. Mellor, 2020. "Do financial incentives matter? Effects of Medicare price shocks on skilled nursing facility care," Health Economics, John Wiley & Sons, Ltd., vol. 29(6), pages 655-670, June.
    3. Brendan Walsh & Seán Lyons & Samantha Smith & Maev‐Ann Wren & James Eighan & Edgar Morgenroth, 2020. "Does formal home care reduce inpatient length of stay?," Health Economics, John Wiley & Sons, Ltd., vol. 29(12), pages 1620-1636, December.
    4. Judite Gonçalves & France Weaver, 2017. "Effects of formal home care on hospitalizations and doctor visits," International Journal of Health Economics and Management, Springer, vol. 17(2), pages 203-233, June.
    5. Norton, E.C., 2016. "Health and Long-Term Care," Handbook of the Economics of Population Aging, in: Piggott, John & Woodland, Alan (ed.), Handbook of the Economics of Population Aging, edition 1, volume 1, chapter 0, pages 951-989, Elsevier.
    6. Elodie Adida & Hamed Mamani & Shima Nassiri, 2017. "Bundled Payment vs. Fee-for-Service: Impact of Payment Scheme on Performance," Management Science, INFORMS, vol. 63(5), pages 1606-1624, May.
    7. Hyunjee Kim & Edward C. Norton, 2015. "Practice Patterns among Entrants and Incumbents in the Home Health Market after the Prospective Payment System was Implemented," Health Economics, John Wiley & Sons, Ltd., vol. 24(S1), pages 118-131, March.
    8. Walsh, Brendan & Wren, Maev-Ann & Smith, Samantha & Lyons, Seán & Eighan, James & Morgenroth, Edgar, 2019. "An analysis of the effects on Irish hospital care of the supply of care inside and outside the hospital," Research Series, Economic and Social Research Institute (ESRI), number RS91.
    9. Chiara Orsini, 2019. "The mortality effects of changing public funding for home health care: An empirical analysis of Medicare home health care in the United States," Health Economics, John Wiley & Sons, Ltd., vol. 28(7), pages 921-936, July.
    10. Keane, Claire & Seán Lyons & Mark Regan & Walsh, Brendan, 2022. "Home support services in Ireland: Exchequer and distributional impacts of funding options," Research Series, Economic and Social Research Institute (ESRI), number SUSTAT111.
    11. Stadhouders, Niek & Kruse, Florien & Tanke, Marit & Koolman, Xander & Jeurissen, Patrick, 2019. "Effective healthcare cost-containment policies: A systematic review," Health Policy, Elsevier, vol. 123(1), pages 71-79.
    12. Jing Gu & Neeraj Sood & Abe Dunn & John Romley, 2019. "Productivity growth of skilled nursing facilities in the treatment of post-acute-care-intensive conditions," PLOS ONE, Public Library of Science, vol. 14(4), pages 1-14, April.

  15. Neeraj Sood & Peter J. Huckfeldt & David C. Grabowski & Joseph P. Newhouse & José J. Escarce, 2011. "The Effect of Prospective Payment on Admission and Treatment Policy: Evidence from Inpatient Rehabilitation Facilities," NBER Working Papers 17125, National Bureau of Economic Research, Inc.

    Cited by:

    1. Neeraj Sood & Abby Alpert & Kayleigh Barnes & Peter Huckfeldt & Jose Escarce, 2015. "Effects of Payment Reform in More versus Less Competitive Markets," NBER Working Papers 21654, National Bureau of Economic Research, Inc.
    2. Daifeng He & Peter McHenry & Jennifer M. Mellor, 2020. "Do financial incentives matter? Effects of Medicare price shocks on skilled nursing facility care," Health Economics, John Wiley & Sons, Ltd., vol. 29(6), pages 655-670, June.
    3. Nicolas Ziebarth, 2014. "Assessing the effectiveness of health care cost containment measures: evidence from the market for rehabilitation care," International Journal of Health Economics and Management, Springer, vol. 14(1), pages 41-67, March.
    4. Newhouse, Joseph Paul & Huckfeldt, Peter J & Grabowski, David C. & Sood, Neeraj & Escarce, Jose J, 2012. "Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems," Scholarly Articles 8506865, Harvard Kennedy School of Government.
    5. Damrongplasit, Kannika & Atalay, Kadir, 2021. "Payment mechanism and hospital admission: New evidence from Thailand healthcare reform," Social Science & Medicine, Elsevier, vol. 291(C).
    6. Laurence Baker & M. Kate Bundorf & Aileen Devlin & Daniel P. Kessler, 2019. "Why Don't Commercial Health Plans Use Prospective Payment?," American Journal of Health Economics, MIT Press, vol. 5(4), pages 465-480, Fall.
    7. Elodie Adida & Hamed Mamani & Shima Nassiri, 2017. "Bundled Payment vs. Fee-for-Service: Impact of Payment Scheme on Performance," Management Science, INFORMS, vol. 63(5), pages 1606-1624, May.
    8. Pott, Clara & Stargardt, Tom & Frey, Simon, 2023. "Does prospective payment influence quality of care? A systematic review of the literature," Social Science & Medicine, Elsevier, vol. 323(C).
    9. Lai, Yi & Fu, Hongqiao & Li, Ling & Yip, Winnie, 2022. "Hospital response to a case-based payment scheme under regional global budget: The case of Guangzhou in China," Social Science & Medicine, Elsevier, vol. 292(C).

  16. Margaret E. Blume-Kohout & Krishna B. Kumar & Neeraj Sood, 2009. "Federal Life Sciences Funding and University R&D," NBER Working Papers 15146, National Bureau of Economic Research, Inc.

    Cited by:

    1. GODEFROY, Raphaël, 2018. "The birth of the congressional clinic," Cahiers de recherche 2018-11, Universite de Montreal, Departement de sciences economiques.
    2. Lauren Lanahan, 2016. "Multilevel public funding for small business innovation: a review of US state SBIR match programs," The Journal of Technology Transfer, Springer, vol. 41(2), pages 220-249, April.
    3. Joshua L Rosenbloom & Donna K Ginther & Ted Juhl & Joseph A Heppert, 2015. "The Effects of Research & Development Funding on Scientific Productivity: Academic Chemistry, 1990-2009," PLOS ONE, Public Library of Science, vol. 10(9), pages 1-23, September.
    4. Margaret Blume-Kohout & Krishna Kumar & Christopher Lau & Neeraj Sood, 2015. "The effect of federal research funding on formation of university-firm biopharmaceutical alliances," The Journal of Technology Transfer, Springer, vol. 40(5), pages 859-876, October.
    5. Elzbieta Pohulak-Zoledowska, 2013. "Property Rights Of Scientific Knowledge In Terms Of Creating Innovation," Oeconomia Copernicana, Institute of Economic Research, vol. 4(1), pages 37-52, March.
    6. Alexander Whalley & Justin Hicks, 2014. "Spending Wisely? How Resources Affect Knowledge Production In Universities," Economic Inquiry, Western Economic Association International, vol. 52(1), pages 35-55, January.
    7. Maryann Feldman & Lauren Lanahan, 2013. "State Science Policy Experiments," NBER Chapters, in: The Changing Frontier: Rethinking Science and Innovation Policy, pages 287-317, National Bureau of Economic Research, Inc.
    8. Daniel Crown & Alessandra Faggian, 2019. "Naturalization and the productivity of foreign-born doctorates," Journal of Geographical Systems, Springer, vol. 21(4), pages 533-556, December.
    9. Leila Tahmooresnejad & Catherine Beaudry & Andrea Schiffauerova, 2015. "The role of public funding in nanotechnology scientific production: Where Canada stands in comparison to the United States," Scientometrics, Springer;Akadémiai Kiadó, vol. 102(1), pages 753-787, January.
    10. Beaudry, Catherine & Allaoui, Sedki, 2012. "Impact of public and private research funding on scientific production: The case of nanotechnology," Research Policy, Elsevier, vol. 41(9), pages 1589-1606.
    11. Richard Jensen & Jerry Thursby & Marie C. Thursby, 2010. "University-Industry Spillovers, Government Funding, and Industrial Consulting," NBER Working Papers 15732, National Bureau of Economic Research, Inc.

  17. Jay Bhattacharya & Kate Bundorf & Noemi Pace & Neeraj Sood, 2009. "Does Health Insurance Make You Fat?," NBER Working Papers 15163, National Bureau of Economic Research, Inc.

    Cited by:

    1. Bernard Black & José-Antonio Espín-Sánchez & Eric French & Kate Litvak, 2017. "The Long-Term Effect of Health Insurance on Near-Elderly Health and Mortality," American Journal of Health Economics, MIT Press, vol. 3(3), pages 281-311, Summer.
    2. Augurzky,Boris & Bauer,Thomas K. & Reichert,Arndt Rudiger & Schmidt,Christoph M. & Tauchmann,Harald, 2015. "Small cash rewards for big losers : experimental insights into the fight against the obesity epidemic," Policy Research Working Paper Series 7339, The World Bank.
    3. Charles J. Courtemanche & Daniela Zapata, 2012. "Does Universal Coverage Improve Health? The Massachusetts Experience," NBER Working Papers 17893, National Bureau of Economic Research, Inc.
    4. Manan Roy, 2011. "How Well Does the U.S. Government Provide Health Insurance?," Departmental Working Papers 1102, Southern Methodist University, Department of Economics.
    5. Charles L. Baum & Shin-Yi Chou, 2011. "The Socio-Economic Causes of Obesity," NBER Working Papers 17423, National Bureau of Economic Research, Inc.
    6. M. Taha Kasim & Benjamin Ukert, 2021. "The impact of WIC participation on tobacco use and alcohol consumption," Contemporary Economic Policy, Western Economic Association International, vol. 39(3), pages 608-625, July.
    7. Soojin Kim & Dirk Krueger & Harold Cole, 2012. "Analyzing the Effects of Insuring Away Health Risks," 2012 Meeting Papers 609, Society for Economic Dynamics.
    8. Fletcher, Jason M. & Frisvold, David E. & Tefft, Nathan, 2010. "The effects of soft drink taxes on child and adolescent consumption and weight outcomes," Journal of Public Economics, Elsevier, vol. 94(11-12), pages 967-974, December.
    9. Jay Bhattacharya & Mikko Packalen, 2008. "The Other Ex-Ante Moral Hazard in Health," NBER Working Papers 13863, National Bureau of Economic Research, Inc.
    10. Fichera, Eleonora & Banks, James & Siciliani, Luigi & Sutton, Matt, 2018. "Does patient health behaviour respond to doctor effort?," Journal of Economic Behavior & Organization, Elsevier, vol. 156(C), pages 225-251.
    11. Dhaval M. Dave & Robert Kaestner & George L. Wehby, 2015. "Does Medicaid Coverage for Pregnant Women Affect Prenatal Health Behaviors?," NBER Working Papers 21049, National Bureau of Economic Research, Inc.
    12. Johanna Catherine Maclean, 2016. "Does Leaving School in an Economic Downturn Persistently Affect Body Weight? Evidence from Panel Data," Industrial Relations: A Journal of Economy and Society, Wiley Blackwell, vol. 55(1), pages 122-148, January.
    13. Augurzky, Boris & Bauer, Thomas K. & Reichert, Arndt R. & Schmidt, Christoph M. & Tauchmann, Harald, 2018. "Habit formation, obesity, and cash rewards," FAU Discussion Papers in Economics 06/2018, Friedrich-Alexander University Erlangen-Nuremberg, Institute for Economics.
    14. Neeraj Sood & Yanyu Wu, 2013. "The Impact of Insurance and HIV Treatment Technology on HIV Testing," NBER Working Papers 19397, National Bureau of Economic Research, Inc.
    15. Cole, Harold & Krueger, Dirk & Kim, Soojin, 2012. "Analyzing the Effects of Insuring Health Risks: On the Trade-off between Short Run Insurance Benefits vs. Long Run Incentive Co," CEPR Discussion Papers 9239, C.E.P.R. Discussion Papers.
    16. Robert Rosenman, 2009. "The Public Finance of Healthy Behavior," Working Papers 2009-18, School of Economic Sciences, Washington State University.
    17. Charles Courtemanche & Garth Heutel & Patrick McAlvanah, 2015. "Impatience, Incentives and Obesity," Economic Journal, Royal Economic Society, vol. 125(582), pages 1-31, February.
    18. Jay Bhattacharya & Neeraj Sood, 2011. "Who Pays for Obesity?," Journal of Economic Perspectives, American Economic Association, vol. 25(1), pages 139-158, Winter.
    19. Harold L. Cole & Soojin Kim & Dirk Krueger, 2012. "Analyzing the Effects of Insuring Health Risks: On the Trade-off between Short Run Insurance Benefits vs. Long Run Incentive Costs," PIER Working Paper Archive 12-047, Penn Institute for Economic Research, Department of Economics, University of Pennsylvania.
    20. John Cawley & Chad Meyerhoefer, 2010. "The Medical Care Costs of Obesity: An Instrumental Variables Approach," NBER Working Papers 16467, National Bureau of Economic Research, Inc.
    21. Chad Cotti & Erik Nesson & Nathan Tefft, 2019. "Impacts of the ACA Medicaid expansion on health behaviors: Evidence from household panel data," Health Economics, John Wiley & Sons, Ltd., vol. 28(2), pages 219-244, February.
    22. Dhaval M. Dave & Robert Kaestner & George L. Wehby, 2019. "Does public insurance coverage for pregnant women affect prenatal health behaviors?," Journal of Population Economics, Springer;European Society for Population Economics, vol. 32(2), pages 419-453, April.
    23. Aparna Soni, 2020. "The effects of public health insurance on health behaviors: Evidence from the fifth year of Medicaid expansion," Health Economics, John Wiley & Sons, Ltd., vol. 29(12), pages 1586-1605, December.
    24. Cawley, John, 2015. "An economy of scales: A selective review of obesity's economic causes, consequences, and solutions," Journal of Health Economics, Elsevier, vol. 43(C), pages 244-268.

  18. Margaret E. Blume-Kohout & Neeraj Sood, 2008. "The Impact of Medicare Part D on Pharmaceutical R&D," NBER Working Papers 13857, National Bureau of Economic Research, Inc.

    Cited by:

    1. Freedman, Seth & Lin, Haizhen & Simon, Kosali, 2015. "Public health insurance expansions and hospital technology adoption," Journal of Public Economics, Elsevier, vol. 121(C), pages 117-131.
    2. Jonathan D. Ketcham & Kosali Simon, 2008. "Medicare Part D's Effects on Elderly Drug Costs and Utilization," NBER Working Papers 14326, National Bureau of Economic Research, Inc.
    3. Margaret K. Kyle, 2019. "The Alignment of Innovation Policy and Social Welfare: Evidence from Pharmaceuticals," NBER Chapters, in: Innovation Policy and the Economy, Volume 20, pages 95-123, National Bureau of Economic Research, Inc.
    4. Paul Grootendorst, 2012. "Prescription Drug Insurance and Reimbursement," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 11, Edward Elgar Publishing.
    5. Claudio Lucarelli & Sean Nicholson & Minjae Song, 2010. "Bundling Among Rivals: A Case of Pharmaceutical Cocktails," NBER Working Papers 16321, National Bureau of Economic Research, Inc.
    6. Jeffrey Clemens, 2013. "The Effect of U.S. Health Insurance Expansions on Medical Innovation," NBER Working Papers 19761, National Bureau of Economic Research, Inc.
    7. Iain M. Cockburn & Scott Stern & Jack Zausner, 2011. "Finding the Endless Frontier: Lessons from the Life Sciences Innovation System for Energy R&D," NBER Chapters, in: Accelerating Energy Innovation: Insights from Multiple Sectors, pages 113-157, National Bureau of Economic Research, Inc.

  19. Adeline Delavande & Dana Goldman & Neeraj Sood, 2007. "Criminal Prosecution and HIV-related Risky Behavior," NBER Working Papers 12903, National Bureau of Economic Research, Inc.

    Cited by:

    1. Raj Arunachalam & Manisha Shah, 2013. "Compensated for Life: Sex Work and Disease Risk," Journal of Human Resources, University of Wisconsin Press, vol. 48(2), pages 345-369.
    2. Delavande, Adeline & Sampaio, Mafalda & Sood, Neeraj, 2014. "HIV-related social intolerance and risky sexual behavior in a high HIV prevalence environment," Social Science & Medicine, Elsevier, vol. 111(C), pages 84-93.

  20. Darius Lakdawalla & Neeraj Sood, 2007. "The Welfare Effects of Public Drug Insurance," NBER Working Papers 13501, National Bureau of Economic Research, Inc.

    Cited by:

    1. Lakdawalla, Darius & Sood, Neeraj & Gu, Qian, 2013. "Pharmaceutical advertising and Medicare Part D," Journal of Health Economics, Elsevier, vol. 32(6), pages 1356-1367.
    2. Volker Grossmann, 2011. "Do Cost-sharing and Entry Deregulation Curb Pharmaceutical Innovation?," CESifo Working Paper Series 3439, CESifo.
    3. Patricia M. Danzon & Adrian K. Towse & Jorge Mestre-Ferrandiz, 2012. "Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context," NBER Working Papers 18593, National Bureau of Economic Research, Inc.
    4. Boone, J., 2013. "Does the Market Choose Optimal Health Insurance Coverage," Discussion Paper 2013-008, Tilburg University, Tilburg Law and Economic Center.
    5. Hostenkamp, Gisela, 2013. "Do follow-on therapeutic substitutes induce price competition between hospital medicines? Evidence from the Danish hospital sector," Health Policy, Elsevier, vol. 111(1), pages 68-77.
    6. Jena, Anupam B. & Philipson, Tomas J., 2013. "Endogenous cost-effectiveness analysis and health care technology adoption," Journal of Health Economics, Elsevier, vol. 32(1), pages 172-180.
    7. Jay Bhattacharya & Mikko Packalen, 2008. "The Other Ex-Ante Moral Hazard in Health," NBER Working Papers 13863, National Bureau of Economic Research, Inc.
    8. Claudio Lucarelli & Jeffrey Prince & Kosali Simon, 2008. "The Welfare Impact of Reducing Choice in Medicare Part D: A Comparison of Two Regulation Strategies," NBER Working Papers 14296, National Bureau of Economic Research, Inc.
    9. Lakdawalla, Darius & Sood, Neeraj, 2013. "Health insurance as a two-part pricing contract," Journal of Public Economics, Elsevier, vol. 102(C), pages 1-12.
    10. Rosella Levaggi & Michele Moretto & Paolo Pertile, 2013. "The dynamics of pharmaceutical regulation and R&D investments," Working Papers 13/2013, University of Verona, Department of Economics.
    11. Thomas Buchmueller & John C. Ham & Lara D. Shore-Sheppard, 2015. "The Medicaid Program," NBER Working Papers 21425, National Bureau of Economic Research, Inc.
    12. Glazer, Jacob & McGuire, Thomas G., 2012. "A welfare measure of “offset effects” in health insurance," Journal of Public Economics, Elsevier, vol. 96(5), pages 520-523.
    13. Tomas J. Philipson & George Zanjani, 2013. "Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension," NBER Working Papers 19005, National Bureau of Economic Research, Inc.
    14. Jeffrey Clemens, 2013. "The Effect of U.S. Health Insurance Expansions on Medical Innovation," NBER Working Papers 19761, National Bureau of Economic Research, Inc.
    15. Lundin Douglas & Ramsberg Joakim, 2008. "Dynamic Cost-Effectiveness: A More Efficient Reimbursement Criterion," Forum for Health Economics & Policy, De Gruyter, vol. 11(2), pages 1-17, November.

  21. Ashlesha Datar & Arkadipta Ghosh & Neeraj Sood, 2007. "Mortality Risks, Health Endowments, and Parental Investments in Infancy: Evidence from Rural India," NBER Working Papers 13649, National Bureau of Economic Research, Inc.

    Cited by:

    1. Schultz, Paul, 2009. "Population and Health Policies," Working Papers 66, Yale University, Department of Economics.
    2. Ruben Castro & Jere Behrman & Hans-Peter Kohler, 2015. "Perception of HIV risk and the quantity and quality of children: the case of rural Malawi," Journal of Population Economics, Springer;European Society for Population Economics, vol. 28(1), pages 113-132, January.

  22. Darius Lakdawalla & Neeraj Sood, 2006. "Health Insurance as a Two-Part Pricing Contract," NBER Working Papers 12681, National Bureau of Economic Research, Inc.

    Cited by:

    1. Herr, Annika & Suppliet, Moritz, 2012. "Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany," DICE Discussion Papers 48, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
    2. Volker Grossmann, 2011. "Do Cost-sharing and Entry Deregulation Curb Pharmaceutical Innovation?," CESifo Working Paper Series 3439, CESifo.
    3. Bognar, Katalin & Romley, John A. & Bae, Jay P. & Murray, James & Chou, Jacquelyn W. & Lakdawalla, Darius N., 2017. "The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions," Journal of Health Economics, Elsevier, vol. 51(C), pages 1-12.
    4. Kyna Fong & Michael Schwarz, 2009. "Towards an Efficient Mechanism for Prescription Drug Procurement," NBER Working Papers 14718, National Bureau of Economic Research, Inc.
    5. Yurong Chen & Zhaohua Chen & Xiaotie Deng & Zhiyi Huang, 2024. "Are Bounded Contracts Learnable and Approximately Optimal?," Papers 2402.14486, arXiv.org.
    6. Darius Lakdawalla & Neeraj Sood, 2007. "The Welfare Effects of Public Drug Insurance," NBER Working Papers 13501, National Bureau of Economic Research, Inc.
    7. Cremer, Helmuth & Lozachmeur, Jean-Marie, 2021. "Coinsurance vs. copayments: reimbursement rules for a monopolistic medical product with competitive health insurers," TSE Working Papers 21-1223, Toulouse School of Economics (TSE).
    8. Jay Bhattacharya & Mikko Packalen, 2008. "The Other Ex-Ante Moral Hazard in Health," NBER Working Papers 13863, National Bureau of Economic Research, Inc.
    9. Rabbani, Maysam, 2024. "Internet price, speed, and disparity: The case of rural healthcare providers in the United States," Telecommunications Policy, Elsevier, vol. 48(2).
    10. Bardey, David & Cremer, Helmuth & Lozachmeur, Jean-Marie, 2015. "The design of insurance coverage for medical products under imperfect competition," TSE Working Papers 15-553, Toulouse School of Economics (TSE).
    11. Lakdawalla, Darius & Sood, Neeraj, 2009. "Innovation and the welfare effects of public drug insurance," Journal of Public Economics, Elsevier, vol. 93(3-4), pages 541-548, April.
    12. Gilad Sorek & Randolph T. Beard, 2016. "Regulating from the Demand Side: Public Health Insurance with Monopolistically Competitive Providers and Optional Spot Sales," Auburn Economics Working Paper Series auwp2016-06, Department of Economics, Auburn University.
    13. Malani, Anup & Philipson, Tomas J., 2011. "Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets," Working Papers 237, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
    14. Chaudhuri, Sarbajit & Kumar Dwibedi, Jayanta & Biswas, Anindya, 2017. "Subsidizing healthcare in the presence of market distortions," Economic Modelling, Elsevier, vol. 64(C), pages 539-552.
    15. Neeraj Sood & Karen Mulligan & Kimberly Zhong, 2021. "Do companies in the pharmaceutical supply chain earn excess returns?," International Journal of Health Economics and Management, Springer, vol. 21(1), pages 99-114, March.
    16. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," Journal of Health Economics, Elsevier, vol. 83(C).
    17. Kremer, Michael & Snyder, Christopher, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global D," CEPR Discussion Papers 12751, C.E.P.R. Discussion Papers.
    18. Adrian Towse & Michele Pistollato & Jorge Mestre-Ferrandiz & Zeba Khan & Satyin Kaura & Louis Garrison, 2015. "European Union Pharmaceutical Markets: A Case for Differential Pricing?," International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 263-275, July.
    19. Ilya Rahkovsky, 2015. "Exclusive Contracts in Health Insurance," Business and Management Research, Business and Management Research, Sciedu Press, vol. 4(2), pages 37-53, June.
    20. Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Other publications TiSEM 6430293b-fde9-4f91-ab35-3, Tilburg University, School of Economics and Management.
    21. Chen, Alice & Lakdawalla, Darius N., 2019. "Healing the poor: The influence of patient socioeconomic status on physician supply responses," Journal of Health Economics, Elsevier, vol. 64(C), pages 43-54.
    22. Eric Helland & Seth A. Seabury, 2016. "Are Settlements in Patent Litigation Collusive? Evidence from Paragraph IV Challenges," NBER Working Papers 22194, National Bureau of Economic Research, Inc.
    23. Michael Kremer & Christopher Snyder, 2015. "Preventives Versus Treatments," NBER Working Papers 21012, National Bureau of Economic Research, Inc.
    24. Leive, Adam & David, Guy & Candon, Molly, 2023. "On resource allocation in health care: The case of concierge medicine," Journal of Health Economics, Elsevier, vol. 90(C).
    25. Tomas J. Philipson & George Zanjani, 2013. "Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension," NBER Working Papers 19005, National Bureau of Economic Research, Inc.
    26. Jakub P. Hlávka & Jeffrey C. Yu & Dana P. Goldman & Darius N. Lakdawalla, 2021. "The economics of alternative payment models for pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 559-569, June.
    27. Atanu Saha & Yong Xu, 2023. "Estimating Brand Drugs’ Payoff from Pay-for-Delay Deals," Journal of Industry, Competition and Trade, Springer, vol. 23(1), pages 81-99, June.
    28. Volker Grossmann, 2021. "Medical Innovations and Ageing: A Health Economics Perspective," CESifo Working Paper Series 9387, CESifo.
    29. Michael Kremer & Christopher M. Snyder, 2018. "Preventives Versus Treatments Redux: Tighter Bounds on Distortions in Innovation Incentives with an Application to the Global Demand for HIV Pharmaceuticals," NBER Working Papers 24206, National Bureau of Economic Research, Inc.
    30. Darius Lakdawalla & Anup Malani & Julian Reif, 2015. "The Insurance Value of Medical Innovation," NBER Working Papers 21015, National Bureau of Economic Research, Inc.
    31. Casey B. Mulligan, 2023. "Beyond Pigou: externalities and civil society in the supply–demand framework," Public Choice, Springer, vol. 196(1), pages 1-18, July.
    32. Mukherjee, Arijit & Zeng, Chenhang, 2022. "Social desirability of entry in a bilateral oligopoly—The implications of (non) sunk costs," Mathematical Social Sciences, Elsevier, vol. 118(C), pages 12-19.
    33. Sorek Gilad & Randolph Beard T., 2018. "Public Health Insurance with Monopolistically Competitive Providers and Optional Spot Sales," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 18(1), pages 1-10, January.
    34. Kremer, Michael & Snyder, Christopher, 2015. "Vaccines vs. Preventives," CEPR Discussion Papers 10474, C.E.P.R. Discussion Papers.

  23. Neeraj Sood & Melinda Beeuwkes Buntin & Jose J. Escarce, 2006. "Does How Much and How You Pay Matter? Evidence from the Inpatient Rehabilitation Facility Prospective Payment System," NBER Working Papers 12556, National Bureau of Economic Research, Inc.

    Cited by:

    1. Galina Besstremyannaya & Dmitry Shapiro, 2012. "Heterogeneous effect of prospective payment system on hospital’s volume and quality," Working Papers w0181, Center for Economic and Financial Research (CEFIR).

  24. Dana Goldman & Neeraj Sood & Arleen Leibowitz, 2005. "Wage and Benefit Changes in Response to Rising Health Insurance Costs," NBER Working Papers 11063, National Bureau of Economic Research, Inc.

    Cited by:

    1. Daron Acemoglu & Andrea Manera & Pascual Restrepo, 2020. "Does the US Tax Code Favor Automation?," NBER Working Papers 27052, National Bureau of Economic Research, Inc.
    2. Jessica Vistnes & Thomas Selden, 2011. "Premium growth and its effect on employer-sponsored insurance," International Journal of Health Economics and Management, Springer, vol. 11(1), pages 55-81, March.
    3. Stéphanie Lluis, 2009. "The Structure of Wages by Firm Size: A Comparison of Canada and the USA," LABOUR, CEIS, vol. 23(2), pages 283-317, June.
    4. Adams, Scott, 2007. "Health insurance market reform and employee compensation: The case of pure community rating in New York," Journal of Public Economics, Elsevier, vol. 91(5-6), pages 1119-1133, June.
    5. DeVaro, Jed & Maxwell, Nan L., 2014. "The elusive wage-benefit trade-off: The case of employer-provided health insurance," International Journal of Industrial Organization, Elsevier, vol. 37(C), pages 23-37.
    6. Nan L. Maxwell, 2008. "Labor Markets And Health Benefits: The Offer And Restrictions On It," Contemporary Economic Policy, Western Economic Association International, vol. 26(1), pages 73-88, January.

  25. Jay Bhattacharya & Neeraj Sood, 2005. "Health Insurance and the Obesity Externality," NBER Working Papers 11529, National Bureau of Economic Research, Inc.

    Cited by:

    1. Eugene Choo & Michael Denny, 2006. "Prior Conditions, Age and the Impact of Insurance," Working Papers tecipa-259, University of Toronto, Department of Economics.
    2. Scott E. Harrington, 2010. "The Health Insurance Reform Debate," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 77(1), pages 5-38, March.
    3. Brunello, Giorgio & Michaud, Pierre-Carl & Sanz-de-Galdeano, Anna, 2008. "The Rise in Obesity across the Atlantic: An Economic Perspective," IZA Discussion Papers 3529, Institute of Labor Economics (IZA).
    4. Jay Bhattacharya & Mikko Packalen, 2008. "The Other Ex-Ante Moral Hazard in Health," NBER Working Papers 13863, National Bureau of Economic Research, Inc.
    5. STANCIOLE Anderson, 2007. "Health Insurance and Life Style Choices: Identifying the Ex Ante Moral Hazard," IRISS Working Paper Series 2007-10, IRISS at CEPS/INSTEAD.
    6. Tomas Philipson & Richard Posner, 2008. "Is the Obesity Epidemic a Public Health Problem? A Decade of Research on the Economics of Obesity," NBER Working Papers 14010, National Bureau of Economic Research, Inc.
    7. Kuku-Shittu, Oluyemisi & Gundersen, Craig & Garasky, Steven B., 2008. "Food insecurity and childhood obesity: beyond categorical and linear representations," 2008 Annual Meeting, July 27-29, 2008, Orlando, Florida 6163, American Agricultural Economics Association (New Name 2008: Agricultural and Applied Economics Association).
    8. Armineh Zohrabian & Tomas J Philipson, 2010. "External Costs of Risky Health Behaviors Associated with Leading Actual Causes of Death in the U.S.: A Review of the Evidence and Implications for Future Research," IJERPH, MDPI, vol. 7(6), pages 1-13, June.
    9. Botkins, Elizabeth Robison, 2015. "Does Health Insurance Encourage Obesity? A Moral Hazard Study," 2015 AAEA & WAEA Joint Annual Meeting, July 26-28, San Francisco, California 206228, Agricultural and Applied Economics Association.
    10. Smith Trenton G. & Stoddard Christiana & Barnes Michael G, 2009. "Why the Poor Get Fat: Weight Gain and Economic Insecurity," Forum for Health Economics & Policy, De Gruyter, vol. 12(2), pages 1-31, June.
    11. Inas Rashad & Sara Markowitz, 2007. "Incentives in Obesity and Health Insurance," NBER Working Papers 13113, National Bureau of Economic Research, Inc.
    12. Michael A. Cohen & Marina-Selini Katsaiti, 2009. "Evaluating Health Care Externality Costs Generated by Risky Consumption Goods," Working papers 2009-43, University of Connecticut, Department of Economics.
    13. Alfredo R. Paloyo & Arndt R. Reichert & Holger Reinermann & Harald Tauchmann, 2014. "The Causal Link Between Financial Incentives And Weight Loss: An Evidence-Based Survey Of The Literature," Journal of Economic Surveys, Wiley Blackwell, vol. 28(3), pages 401-420, July.
    14. Courtemanche, Charles & Carden, Art, 2009. "The skinny on big box retailing: Wal-Mart, warehouse clubs, and obesity," MPRA Paper 25326, University Library of Munich, Germany.
    15. Mary A. Burke & Frank Heiland, 2006. "Social dynamics of obesity," Public Policy Discussion Paper 06-5, Federal Reserve Bank of Boston.
    16. Jay Bhattacharya & Neeraj Sood, 2011. "Who Pays for Obesity?," Journal of Economic Perspectives, American Economic Association, vol. 25(1), pages 139-158, Winter.
    17. Courtemanche, Charles & Carden, Art, 2008. "Supersizing Supercenters? The Impact of Wal-Mart Supercenters on Body Mass Index and Obesity," UNCG Economics Working Papers 09-3, University of North Carolina at Greensboro, Department of Economics, revised 01 Jan 2010.
    18. John Cawley & Chad Meyerhoefer, 2010. "The Medical Care Costs of Obesity: An Instrumental Variables Approach," NBER Working Papers 16467, National Bureau of Economic Research, Inc.
    19. Li, Xun & Pan, Wensi & Xu, Gang, 2024. "A “leaner” government? The effect of China's anti-corruption campaign on the body weight and health of public sector employees," Journal of Economic Behavior & Organization, Elsevier, vol. 217(C), pages 141-169.
    20. Sara Bleich & David Cutler & Christopher Murray & Alyce Adams, 2007. "Why Is The Developed World Obese?," NBER Working Papers 12954, National Bureau of Economic Research, Inc.
    21. Augurzky, Boris & Bauer, Thomas K. & Reichert, Arndt R. & Schmidt, Christoph M. & Tauchmann, Harald, 2012. "Does Money Burn Fat? – Evidence from a Randomized Experiment," Ruhr Economic Papers 368, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    22. Ralph Bradley & Colin Baker, 2013. "The Simultaneous Effects of Obesity, Insurance Choice, and Medical Visit Choice on Health Care Costs," NBER Chapters, in: Measuring and Modeling Health Care Costs, pages 211-240, National Bureau of Economic Research, Inc.
    23. Tomas J. Philipson & Richard A. Posner, 2008. "Is the Obesity Epidemic a Public Health Problem? A Review of Zoltan J. Acs and Alan Lyles's Obesity, Business and Public Policy," Journal of Economic Literature, American Economic Association, vol. 46(4), pages 974-982, December.
    24. Bhattacharya, Jay & Bundorf, M. Kate, 2009. "The incidence of the healthcare costs of obesity," Journal of Health Economics, Elsevier, vol. 28(3), pages 649-658, May.
    25. Bronfman, Javier, 2014. "Universal health insurance under a dual system, evidence of adverse selection against the public sector: the case of Chile," MPRA Paper 63262, University Library of Munich, Germany.
    26. Veiga, Paula, 2008. "Out-of-pocket health care expenditures due to excess of body weight in Portugal," Economics & Human Biology, Elsevier, vol. 6(1), pages 127-142, March.
    27. Donald L. Alexander & Jon R. Neill, 2017. "Estimating the Corrective Tax for Goods whose Consumption Affects the Consumer’s Health," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 45(1), pages 103-117, March.

  26. Darius Lakdawalla & Neeraj Sood, 2005. "Insurance and Innovation in Health Care Markets," NBER Working Papers 11602, National Bureau of Economic Research, Inc.

    Cited by:

    1. Jena, Anupam B. & Philipson, Tomas J., 2008. "Cost-effectiveness analysis and innovation," Journal of Health Economics, Elsevier, vol. 27(5), pages 1224-1236, September.
    2. Volker Grossmann, 2011. "Do Cost-sharing and Entry Deregulation Curb Pharmaceutical Innovation?," CESifo Working Paper Series 3439, CESifo.
    3. Patricia M. Danzon & Adrian K. Towse & Jorge Mestre-Ferrandiz, 2012. "Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context," NBER Working Papers 18593, National Bureau of Economic Research, Inc.
    4. Alan M. Garber & Charles I. Jones & Paul M. Romer, 2006. "Insurance and Incentives for Medical Innovation," NBER Working Papers 12080, National Bureau of Economic Research, Inc.
    5. Siadat, Banafsheh & Stolpe, Michael, 2005. "Reforming health care finance: What can Germany learn from other countries?," Kiel Economic Policy Papers 5, Kiel Institute for the World Economy (IfW Kiel).

  27. Neeraj Sood & Abby Alpert & Jay Bhattacharya, 2005. "Technology, Monopoly, and the Decline of the Viatical Settlements Industry," NBER Working Papers 11164, National Bureau of Economic Research, Inc.

    Cited by:

    1. Mar Jori & Antonio Alegre & Carmen Ribas, 2011. "Deciding the sale of a life policy in the viatical market: Implications on individual welfare," Working Papers in Economics 256, Universitat de Barcelona. Espai de Recerca en Economia.

  28. Dana Goldman & Darius Lakdawalla & Neeraj Sood, 2004. "HIV Breakthroughs and Risk Sexual Behavior," NBER Working Papers 10516, National Bureau of Economic Research, Inc.

    Cited by:

    1. Hugo M. Mialon & Erik T. Nesson & Michael C. Samuel, 2016. "Crystal Clear? The Relationship Between Methamphetamine Use and Sexually Transmitted Infections," Health Economics, John Wiley & Sons, Ltd., vol. 25(3), pages 292-313, March.
    2. Barron, Kai & Gamboa, Luis F. & Rodríguez-Lesmes, Paul, 2019. "Behavioural Response to a Sudden Health Risk: Dengue and Educational Outcomes in Colombia," EconStor Open Access Articles and Book Chapters, ZBW - Leibniz Information Centre for Economics, vol. 55(4), pages 620-644.
    3. Philipp Kircher & Michele Tertilt & Cezar Santos & Jeremy Greenwood, 2013. "An Equilibrium Model of the African HIV/AIDS Epidemic," 2013 Meeting Papers 195, Society for Economic Dynamics.
    4. Immordino, G. & Russo, F.F., 2015. "Regulating prostitution: A health risk approach," Journal of Public Economics, Elsevier, vol. 121(C), pages 14-31.
    5. Guimarães, Luís, 2021. "Antibody tests: They are more important than we thought," Journal of Mathematical Economics, Elsevier, vol. 93(C).
    6. Jean-Claude Berthélemy & Victor Doubliez & Josselin Thuilliez, 2015. "Prevention or treatment? The introduction of a new antimalarial drug in Angola," Documents de travail du Centre d'Economie de la Sorbonne 15089, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne.
    7. Kai Barron & Charles D.H. Parry & Debbie Bradshaw & Rob Dorrington & Pam Groenewald & Ria Laubscher & Richard Matzopoulos, 2022. "Alcohol, Violence and Injury-Induced Mortality: Evidence from a Modern-Day Prohibition," CESifo Working Paper Series 9595, CESifo.
    8. Jay Bhattacharya & M. Kate Bundorf & Noemi Pace & Neeraj Sood, 2011. "Does Health Insurance Make You Fat?," NBER Chapters, in: Economic Aspects of Obesity, pages 35-64, National Bureau of Economic Research, Inc.
    9. Smart, Shanike J. & Polachek, Solomon, 2024. "COVID-19 Vaccine and Risk-Taking," IZA Discussion Papers 16707, Institute of Labor Economics (IZA).
    10. Heinsalu, Sander, 2021. "Promotion of (interaction) abstinence increases infection prevalence," Journal of Economic Behavior & Organization, Elsevier, vol. 186(C), pages 94-112.
    11. Masahiro Shoji & Susumu Cato & Takashi Iida & Kenji Ishida & Asei Ito & Kenneth Mori McElwain, 2022. "Variations in Early-Stage Responses to Pandemics: Survey Evidence from the COVID-19 Pandemic in Japan," Economics of Disasters and Climate Change, Springer, vol. 6(2), pages 235-258, July.
    12. Hussey, Andrew & Nikolsko-Rzhevskyy, Alex & Walker, Jay, 2010. "AIDing Contraception: HIV and Recent Trends in Abortion Rates," MPRA Paper 20895, University Library of Munich, Germany.
    13. Daniel Bennett & Chun-Fang Chiang & Anup Malani, 2011. "Learning During a Crisis: the SARS Epidemic in Taiwan," NBER Working Papers 16955, National Bureau of Economic Research, Inc.
    14. Francis, Andrew M., 2008. "The economics of sexuality: The effect of HIV/AIDS on homosexual behavior in the United States," Journal of Health Economics, Elsevier, vol. 27(3), pages 675-689, May.
    15. Hugo M. Mialon, & Erik Nesson & Michael C. Samuel, 2013. "Crystal Clear? The Relationship between Methamphetamine Use and Risky Sexual Behavior," Working Papers 201301, Ball State University, Department of Economics, revised Mar 2013.
    16. Fichera, Eleonora & Banks, James & Siciliani, Luigi & Sutton, Matt, 2018. "Does patient health behaviour respond to doctor effort?," Journal of Economic Behavior & Organization, Elsevier, vol. 156(C), pages 225-251.
    17. Bryan Engelhardt & Mark R. Kurt & Philip M. Polgreen, 2013. "Sexually Transmitted Infections With Semi‐Anonymous Matching," Health Economics, John Wiley & Sons, Ltd., vol. 22(11), pages 1295-1317, November.
    18. Neeraj Sood & Yanyu Wu, 2013. "The Impact of Insurance and HIV Treatment Technology on HIV Testing," NBER Working Papers 19397, National Bureau of Economic Research, Inc.
    19. Mendolia, Silvia & Stavrunova, Olena & Yerokhin, Oleg, 2021. "Determinants of the community mobility during the COVID-19 epidemic: The role of government regulations and information," Journal of Economic Behavior & Organization, Elsevier, vol. 184(C), pages 199-231.
    20. Friedman, Willa Helterline, 2018. "Antiretroviral drug access and behavior change," Journal of Development Economics, Elsevier, vol. 135(C), pages 392-411.
    21. Malani, Anup & Philipson, Tomas J., 2011. "Can Medical Progress be Sustained? Implications of the Link Between Development and Output Markets," Working Papers 237, The University of Chicago Booth School of Business, George J. Stigler Center for the Study of the Economy and the State.
    22. Betsey Stevenson & Justin Wolfers, 2007. "Marriage and divorce: changes and their driving forces," Working Paper Series 2007-03, Federal Reserve Bank of San Francisco.
    23. Jackson, C. Kirabo & Owens, Emily Greene, 2011. "One for the road: Public transportation, alcohol consumption, and intoxicated driving," Journal of Public Economics, Elsevier, vol. 95(1), pages 106-121.
    24. Fischer, Gregory & Berry, James & Guiteras, Raymond, 2012. "Eliciting and utilizing willingness to pay: evidence from field trials in Northern Ghana," LSE Research Online Documents on Economics 47913, London School of Economics and Political Science, LSE Library.
    25. Staněk, Rostislav & Krčál, Ondřej & Čellárová, Katarína, 2022. "Pull yourself up by your bootstraps: Identifying procedural preferences against helping others in the presence of moral hazard," Journal of Behavioral and Experimental Economics (formerly The Journal of Socio-Economics), Elsevier, vol. 98(C).
    26. Mannberg, Andréa, 2012. "Risk and rationalization—The role of affect and cognitive dissonance for sexual risk taking," European Economic Review, Elsevier, vol. 56(6), pages 1325-1337.
    27. David Canning, 2006. "The Economics of HIV/AIDS in Low-Income Countries: The Case for Prevention," Journal of Economic Perspectives, American Economic Association, vol. 20(3), pages 121-142, Summer.
    28. Derksen, Laura & Muula, Adamson & van Oosterhout, Joep, 2022. "Love in the time of HIV: How beliefs about externalities impact health behavior," Journal of Development Economics, Elsevier, vol. 159(C).
    29. Davide La Torre & Tufail Malik & Simone Marsiglio, 2019. "Optimal Control of Prevention and Treatment in a Basic Macroeconomic-Epidemiological Model," Papers 1910.03383, arXiv.org.
    30. Adeline Delavande, 2012. "HIV/AIDS-related Expectations and Risky Sexual Behavior in Malawi," 2012 Meeting Papers 90, Society for Economic Dynamics.
    31. Chen, Kong-Pin & Yang, Jui-Chung & Yang, Tzu-Ting, 2022. "JUE insight: Demand for transportation and spatial pattern of economic activity during the pandemic," Journal of Urban Economics, Elsevier, vol. 127(C).
    32. Noel Rapa, 2021. "Mitigation measures, prevalence response and public mobility during the COVID-19 emergency," CBM Working Papers WP/03/2021, Central Bank of Malta.
    33. Nicholas Wilson, 2010. "Antiretroviral Therapy and Demand for HIV Testing: Evidence from Zambia," Center for Development Economics 2011-01, Department of Economics, Williams College.
    34. Xue Qiao, 2012. "Unsafe sex, AIDS and development," Journal of Economics, Springer, vol. 105(3), pages 263-279, April.
    35. Sander Heinsalu, 2019. "When abstinence increases prevalence," Papers 1905.02073, arXiv.org.
    36. Liang, Jian & Alexeev, Sergey, 2023. "Harm reduction or amplification? The adverse impact of a supervised injection room on housing prices," Regional Science and Urban Economics, Elsevier, vol. 98(C).
    37. Adeline Delavande & Dana Goldman & Neeraj Sood, 2007. "Criminal Prosecution and HIV-related Risky Behavior," NBER Working Papers 12903, National Bureau of Economic Research, Inc.
    38. Adeline Delavande & Dana Goldman & Neeraj Sood, 2010. "Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior," Journal of Law and Economics, University of Chicago Press, vol. 53(4), pages 741-782.
    39. Ibáñez, Ana María & Rozo, Sandra V. & Urbina, María J., 2021. "Forced Migration and the Spread of Infectious Diseases," Journal of Health Economics, Elsevier, vol. 79(C).
    40. Yakubenko, Slava, 2021. "Home alone? Effect of weather-induced behaviour on spread of SARS-CoV-2 in Germany," Economics & Human Biology, Elsevier, vol. 42(C).
    41. Barron, Kai & Bradshaw, Debbie & Parry, Charles D. H. & Dorrington, Rob & Groenewald, Pam & Laubscher, Ria & Matzopoulos, Richard, 2021. "Alcohol and Short-Run Mortality: Evidence from a Modern-Day Prohibition," Rationality and Competition Discussion Paper Series 273, CRC TRR 190 Rationality and Competition.
    42. Wilson, Nicholas L. & Xiong, Wentao & Mattson, Christine L., 2014. "Is sex like driving? HIV prevention and risk compensation," Journal of Development Economics, Elsevier, vol. 106(C), pages 78-91.
    43. Francis, Andrew M. & Mialon, Hugo M. & Peng, Handie, 2012. "In sickness and in health: Same-sex marriage laws and sexually transmitted infections," Social Science & Medicine, Elsevier, vol. 75(8), pages 1329-1341.
    44. Spencer, Melissa K., 2024. "Safer sex? The effect of AIDS risk on birth rates," Journal of Health Economics, Elsevier, vol. 95(C).
    45. Doleac, Jennifer & Mukherjee, Anita, 2018. "The Moral Hazard of Lifesaving Innovations: Naloxone Access, Opioid Abuse, and Crime," IZA Discussion Papers 11489, Institute of Labor Economics (IZA).
    46. Andrew M. Jones, 2007. "Identification of treatment effects in Health Economics," Health Economics, John Wiley & Sons, Ltd., vol. 16(11), pages 1127-1131, November.
    47. Sabine Liebenehm & Bernard Bett & Cristobal Verdugo & Mohamed Said, 2016. "Optimal Drug Control under Risk of Drug Resistance – The Case of African Animal Trypanosomosis," Journal of Agricultural Economics, Wiley Blackwell, vol. 67(2), pages 510-533, June.

  29. Dana P. Goldman & Neeraj Sood & Arleen Leibowitz, 2003. "The Reallocation of Compensation in Response to Health Insurance Premium Increases," NBER Working Papers 9540, National Bureau of Economic Research, Inc.

    Cited by:

    1. Stéphanie Lluis & Jean Abraham, 2013. "The Wage–Health Insurance Trade-off and Worker Selection: Evidence From the Medical Expenditure Panel Survey 1997 to 2006," Industrial Relations: A Journal of Economy and Society, Wiley Blackwell, vol. 52(2), pages 541-581, April.
    2. Patricia Crifo & Marc-Arthur Diaye, 2011. "The Composition of Compensation Policy: From Cash to Fringe Benefits," Annals of Economics and Statistics, GENES, issue 101-102, pages 307-326.
    3. Vikström, Johan, 2009. "The effect of employer incentives in social insurance on individual wages," Working Paper Series 2009:13, IFAU - Institute for Evaluation of Labour Market and Education Policy.

  30. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2003. "Market Evidence of Misperceived Prices and Mistaken Mortality Risks," NBER Working Papers 9863, National Bureau of Economic Research, Inc.

    Cited by:

    1. Alma Cohen & Peter Siegelman, 2010. "Testing for Adverse Selection in Insurance Markets," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 77(1), pages 39-84, March.
    2. Yamamoto, Shinichi & 山本, 信一 & Yoneyama, Takau & 米山, 高生 & Kwon, W. Jean, 2012. "An Experimental Study On Adverse Selection And Moral Hazard," Hitotsubashi Journal of commerce and management, Hitotsubashi University, vol. 46(1), pages 51-64, October.
    3. Milevsky, Moshe A. & Young, Virginia R., 2007. "Annuitization and asset allocation," Journal of Economic Dynamics and Control, Elsevier, vol. 31(9), pages 3138-3177, September.
    4. Sandroni, Alvaro & Squintani, Francesco, 2013. "Overconfidence and asymmetric information: The case of insurance," Journal of Economic Behavior & Organization, Elsevier, vol. 93(C), pages 149-165.

  31. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2002. "The Link Between Public and Private Insurance and HIV-Related Mortality," NBER Working Papers 9346, National Bureau of Economic Research, Inc.

    Cited by:

    1. Dana P. Goldman & Benjamin G. Cohen & Jessica Y. Ho & Daniel L. McFadden & Martha S. Ryan & Bryan Tysinger, 2021. "Improved survival for individuals with common chronic conditions in the Medicare population," Health Economics, John Wiley & Sons, Ltd., vol. 30(S1), pages 80-91, November.
    2. Qin, Xuezheng & Pan, Jay & Liu, Gordon G., 2014. "Does participating in health insurance benefit the migrant workers in China? An empirical investigation," China Economic Review, Elsevier, vol. 30(C), pages 263-278.
    3. Dana Goldman & Nicole Maestas, 2013. "Medical Expenditure Risk And Household Portfolio Choice," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 28(4), pages 527-550, June.
    4. Neeraj Sood & Zachary Wagner & Yanyu Wu, 2015. "The Impact of Insurance on HIV Testing," American Journal of Health Economics, University of Chicago Press, vol. 1(4), pages 515-536, Fall.
    5. Lawrence P.O. Were & Joseph W Hogan & Omar Galárraga & Richard Wamai, 2020. "Predictors of Health Insurance Enrollment among HIV Positive Pregnant Women in Kenya: Potential for Adverse Selection and Implications for HIV Treatment and Prevention," IJERPH, MDPI, vol. 17(8), pages 1-14, April.
    6. Yingying Meng & Junqiang Han & Siqi Qin, 2018. "The Impact of Health Insurance Policy on the Health of the Senior Floating Population—Evidence from China," IJERPH, MDPI, vol. 15(10), pages 1-17, October.
    7. Tomas J. Philipson & Anupam B. Jena, 2005. "Who Benefits from New Medical Technologies? Estimates of Consumer and Producer Surpluses for HIV/AIDS Drugs," NBER Working Papers 11810, National Bureau of Economic Research, Inc.
    8. Neeraj Sood & Yanyu Wu, 2013. "The Impact of Insurance and HIV Treatment Technology on HIV Testing," NBER Working Papers 19397, National Bureau of Economic Research, Inc.
    9. Meyerhoefer, Chad D. & Pylypchuk, Vuriy, 2008. "AJAE Appendix: Does Participation in the Food Stamp Program Increase the Prevalence of Obesity and Health Care Spending?," American Journal of Agricultural Economics APPENDICES, Agricultural and Applied Economics Association, vol. 90(2), pages 1-6.
    10. Xiao Hu & Zhengjie Wang & Jun Liu, 2022. "The impact of digital finance on household insurance purchases: evidence from micro data in China," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 47(3), pages 538-568, July.
    11. Nyman, John A. & Koc, Cagatay & Dowd, Bryan E. & McCreedy, Ellen & Trenz, Helen Markelova, 2018. "Decomposition of moral hazard," Journal of Health Economics, Elsevier, vol. 57(C), pages 168-178.
    12. Duggan Mark G & Evans William N, 2008. "Estimating the Impact of Medical Innovation: A Case Study of HIV Antiretroviral Treatments," Forum for Health Economics & Policy, De Gruyter, vol. 11(2), pages 1-39, January.
    13. Jay Pan & Xiaoyan Lei & Gordon G. Liu, 2016. "Health Insurance and Health Status: Exploring the Causal Effect from a Policy Intervention," Health Economics, John Wiley & Sons, Ltd., vol. 25(11), pages 1389-1402, November.
    14. Kelaher, Margaret & Jessop, Dorothy Jones, 2006. "The impact of loss of Medicaid on health service utilization among persons with HIV/AIDS in New York City," Health Policy, Elsevier, vol. 76(1), pages 80-92, March.
    15. Glied, Sherry & Hong, Kai, 2018. "Health care in a multi-payer system: Spillovers of health care service demand among adults under 65 on utilization and outcomes in medicare," Journal of Health Economics, Elsevier, vol. 60(C), pages 165-176.
    16. PAN, Jay & QIN, Xuezheng & LIU, Gordon G., 2013. "The impact of body size on urban employment: Evidence from China," China Economic Review, Elsevier, vol. 27(C), pages 249-263.
    17. Adeline Delavande & Dana Goldman & Neeraj Sood, 2010. "Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior," Journal of Law and Economics, University of Chicago Press, vol. 53(4), pages 741-782.
    18. Gabriel Picone & Arseniy Yashkin & Thomas Mroz & Frank Sloan, 2013. "Screening for a Chronic Disease: A Multiple Stage Duration Model with Partial Observability," Working Papers 0213, University of South Florida, Department of Economics.
    19. Huh, Jason & Reif, Julian, 2017. "Did Medicare Part D reduce mortality?," Journal of Health Economics, Elsevier, vol. 53(C), pages 17-37.
    20. Bryan Dowd & Matthew L. Maciejewski & Heidi O'Connor & Gerald Riley & Yisong Geng, 2011. "Health plan enrollment and mortality in the Medicare program," Health Economics, John Wiley & Sons, Ltd., vol. 20(6), pages 645-659, June.

  32. Neeraj Sood & Arkadipta Ghosh & José J. Escarce, "undated". "Employer-Sponsored Insurance, Health Care Cost Growth, and the Economic Performance of U.S. Industries," Mathematica Policy Research Reports 88ac266a27d2497c84f0a2db7, Mathematica Policy Research.

    Cited by:

    1. David M. Cutler, 2011. "Where Are the Health Care Entrepreneurs? The Failure of Organizational Innovation in Health Care," Innovation Policy and the Economy, University of Chicago Press, vol. 11(1), pages 1-28.

Articles

  1. Lee, Ryan C. & Sood, Neeraj & Deva, Sohini & Macedo, Marisol & Soto, Daniel W. & Unger, Jennifer B., 2023. "Evaluation of a COVID-19 rapid antigen testing program among student athletes in a public high school district," Evaluation and Program Planning, Elsevier, vol. 98(C).

    Cited by:

    1. S.T, Pavan Kumar & Lahiri, Biswajit, 2023. "Conditional selection of multifactor evidence for the levels of anaemia among women of reproductive age group," Evaluation and Program Planning, Elsevier, vol. 100(C).

  2. Alpert, Abby & Lakdawalla, Darius & Sood, Neeraj, 2023. "Prescription drug advertising and drug utilization: The role of Medicare Part D," Journal of Public Economics, Elsevier, vol. 221(C).
    See citations under working paper version above.
  3. Zachary Wagner & Somalee Banerjee & Manoj Mohanan & Neeraj Sood, 2023. "Does the market reward quality? Evidence from India," International Journal of Health Economics and Management, Springer, vol. 23(3), pages 467-505, September.
    See citations under working paper version above.
  4. Cantor, Jonathan & Sood, Neeraj & Bravata, Dena M. & Pera, Megan & Whaley, Christopher, 2022. "The impact of the COVID-19 pandemic and policy response on health care utilization: Evidence from county-level medical claims and cellphone data," Journal of Health Economics, Elsevier, vol. 82(C).
    See citations under working paper version above.
  5. Rabideau, Brendan & Eisenberg, Matthew D. & Reid, Rachel & Sood, Neeraj, 2021. "Effects of employer-offered high-deductible plans on low-value spending in the privately insured population," Journal of Health Economics, Elsevier, vol. 76(C).

    Cited by:

    1. Rabbani, Maysam, 2021. "Mergers with Future Rivals Can Boost Prices, Intensify Market Concentration, and Bar Entry," MPRA Paper 112864, University Library of Munich, Germany, revised 26 Apr 2022.

  6. Neeraj Sood & Karen Mulligan & Kimberly Zhong, 2021. "Do companies in the pharmaceutical supply chain earn excess returns?," International Journal of Health Economics and Management, Springer, vol. 21(1), pages 99-114, March.

    Cited by:

    1. Fatemi, Maedeh S. & Ghodratnama, Ali & Tavakkoli-Moghaddam, Reza & Kaboli, Amin, 2022. "A multi-functional tri-objective mathematical model for the pharmaceutical supply chain considering congestion of drugs in factories," Research in Transportation Economics, Elsevier, vol. 92(C).

  7. Jing Gu & Neeraj Sood & Abe Dunn & John Romley, 2019. "Productivity growth of skilled nursing facilities in the treatment of post-acute-care-intensive conditions," PLOS ONE, Public Library of Science, vol. 14(4), pages 1-14, April.

    Cited by:

    1. John A. Romley & Dana Goldman & Neeraj Sood & Abe C. Dunn, 2019. "Quantifying Productivity Growth in the Delivery of Important Episodes of Care Within the Medicare Program Using Insurance Claims and Administrative Data," BEA Papers 0111, Bureau of Economic Analysis.

  8. Chatterjee, Chirantan & Joshi, Radhika & Sood, Neeraj & Boregowda, P., 2018. "Government health insurance and spatial peer effects: New evidence from India," Social Science & Medicine, Elsevier, vol. 196(C), pages 131-141.

    Cited by:

    1. Malani, Anup & Kinnan, Cynthia & Conti, Gabriella & Imai, Kosuke & Miller, Morgen & Swaminathan, Shailender & Voena, Alessandra & Woda, Bartek, 2024. "Evaluating and Pricing Health Insurance in Lower-Income Countries: A Field Experiment in India," IZA Discussion Papers 16861, Institute of Labor Economics (IZA).
    2. Sawan Rathi & Anindya S. Chakrabarti & Chirantan Chatterjee & Aparna Hegde, 2022. "Pandemics and technology engagement: New evidence from m‐Health intervention during COVID‐19 in India," Review of Development Economics, Wiley Blackwell, vol. 26(4), pages 2184-2217, November.
    3. Chen, Bingzheng & Feng, Frank Y. & Powers, Michael R. & Qiu, Joseph, 2019. "Risk-revealing contracts for government-sponsored microinsurance," Pacific-Basin Finance Journal, Elsevier, vol. 57(C).
    4. Biroli, Pietro & Zwyssig, Laura, 2021. "Moral Hazard Heterogeneity: Genes and Health Insurance Influence Smoking after a Health Shock," IZA Discussion Papers 14176, Institute of Labor Economics (IZA).
    5. Deo, Sarang & Tyagi, Hanu & Chatterjee, Chirantan & Molakapuri, Himasagar, 2020. "Did India's price control policy for coronary stents create unintended consequences?," Social Science & Medicine, Elsevier, vol. 246(C).

  9. Mariana Carrera & Dana P. Goldman & Geoffrey Joyce & Neeraj Sood, 2018. "Do Physicians Respond to the Costs and Cost-Sensitivity of Their Patients?," American Economic Journal: Economic Policy, American Economic Association, vol. 10(1), pages 113-152, February.

    Cited by:

    1. Villas-Boas, Sofia B & Carrera, Mariana, 2016. "Generic aversion and observational learning in the over-the-counter drug market," Department of Agricultural & Resource Economics, UC Berkeley, Working Paper Series qt0q03b5f2, Department of Agricultural & Resource Economics, UC Berkeley.
    2. Christian Posso & Jorge Tamayo & Arlen Guarin & Estefania Saravia, 2024. "Luck of the Draw: The Causal Effect of Physicians on Birth Outcomes," Borradores de Economia 1269, Banco de la Republica de Colombia.
    3. Suppliet, Moritz, 2017. "Umbrella Branding in Pharmaceutical Markets," Discussion Paper 2017-034, Tilburg University, Tilburg Law and Economic Center.
    4. Newham, Melissa & Valente, Marica, 2024. "The cost of influence: How gifts to physicians shape prescriptions and drug costs," Journal of Health Economics, Elsevier, vol. 95(C).
    5. Wu, Bingxiao, 2019. "Physician agency in China: Evidence from a drug-percentage incentive scheme," Journal of Development Economics, Elsevier, vol. 140(C), pages 72-89.
    6. Lee, Chung-Ying, 2020. "Pricing strategy and moral hazard: Copay coupons in pharmaceuticals," International Journal of Industrial Organization, Elsevier, vol. 70(C).
    7. Laura V Minard & Amber Corkum & Ingrid Sketris & Judith Fisher & Ying Zhang & Ahmed Saleh, 2016. "Trends in Statin Use in Seniors 1999 to 2013: Time Series Analysis," PLOS ONE, Public Library of Science, vol. 11(7), pages 1-15, July.
    8. Christopher Bates & Susan J. Méndez, 2024. "Therapeutic Substitution in Response to Patent Expiry? Statins in Australia," Economic Papers, The Economic Society of Australia, vol. 43(2), pages 112-123, June.
    9. Rabideau, Brendan & Eisenberg, Matthew D. & Reid, Rachel & Sood, Neeraj, 2021. "Effects of employer-offered high-deductible plans on low-value spending in the privately insured population," Journal of Health Economics, Elsevier, vol. 76(C).
    10. Magno, Cielo & Guzman, Ricardo Rafael S., 2019. "Drug price sensitivity among physicians in a developing healthcare system: Evidence from the Philippine market for statins and beta blockers," Economic Analysis and Policy, Elsevier, vol. 62(C), pages 268-279.
    11. Meng-Chi Tang & Yi-Nong Wu, 2020. "Medical providers as double agents in a universal health care system: evidence from generic pharmaceutical adoption in Taiwan," Empirical Economics, Springer, vol. 59(1), pages 169-203, July.
    12. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," Journal of Health Economics, Elsevier, vol. 83(C).
    13. Fiorentini, Gianluca & Bruni, Matteo Lippi & Mammi, Irene, 2022. "The same old medicine but cheaper: The impact of patent expiry on physicians’ prescribing behaviour," Journal of Economic Behavior & Organization, Elsevier, vol. 204(C), pages 37-68.
    14. Sebastian Linde & Brandon Norton & Ralph Siebert, 2019. "The Effect of Bargaining Power Determinants on Pharmaceutical Prices," CESifo Working Paper Series 7988, CESifo.
    15. Ghosh, Ausmita & Simon, Kosali & Sommers, Benjamin D., 2019. "The Effect of Health Insurance on Prescription Drug Use Among Low-Income Adults:Evidence from Recent Medicaid Expansions," Journal of Health Economics, Elsevier, vol. 63(C), pages 64-80.
    16. Kyle, Margaret K., 2022. "Incentives for pharmaceutical innovation: What’s working, what’s lacking," International Journal of Industrial Organization, Elsevier, vol. 84(C).

  10. Barnes, Kayleigh & Mukherji, Arnab & Mullen, Patrick & Sood, Neeraj, 2017. "Financial risk protection from social health insurance," Journal of Health Economics, Elsevier, vol. 55(C), pages 14-29.
    See citations under working paper version above.
  11. Sood, Neeraj & Alpert, Abby & Barnes, Kayleigh & Huckfeldt, Peter & Escarce, José J., 2017. "Effects of payment reform in more versus less competitive markets," Journal of Health Economics, Elsevier, vol. 51(C), pages 66-83.
    See citations under working paper version above.
  12. Eisenberg, Matthew D. & Haviland, Amelia M. & Mehrotra, Ateev & Huckfeldt, Peter J. & Sood, Neeraj, 2017. "The long term effects of “Consumer-Directed” health plans on preventive care use," Journal of Health Economics, Elsevier, vol. 55(C), pages 61-75.

    Cited by:

    1. Rabideau, Brendan & Eisenberg, Matthew D. & Reid, Rachel & Sood, Neeraj, 2021. "Effects of employer-offered high-deductible plans on low-value spending in the privately insured population," Journal of Health Economics, Elsevier, vol. 76(C).
    2. Salvi, Irene & Cordier, Johannes & Kuklinski, David & Vogel, Justus & Geissler, Alexander, 2023. "Price sensitivity and demand for healthcare services: Investigating demand-side financial incentives using anonymised claims data from Switzerland," Working Paper Series in Health Economics, Management and Policy 2023-06, University of St.Gallen, School of Medicine, Chair of Health Economics, Policy and Management.

  13. Geoffrey F. Joyce & Neeraj Sood, 2016. "Why Medicare Price Negotiation Is The Wrong Prescription For Rising Drug Spending: Response To Rena Conti," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., vol. 35(4), pages 970-972, September.

    Cited by:

    1. Michael D. Frakes & Melissa F. Wasserman, 2020. "Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination," NBER Working Papers 27579, National Bureau of Economic Research, Inc.

  14. Haviland, Amelia M. & Eisenberg, Matthew D. & Mehrotra, Ateev & Huckfeldt, Peter J. & Sood, Neeraj, 2016. "Do “Consumer-Directed” health plans bend the cost curve over time?," Journal of Health Economics, Elsevier, vol. 46(C), pages 33-51.
    See citations under working paper version above.
  15. Margaret Blume-Kohout & Krishna Kumar & Christopher Lau & Neeraj Sood, 2015. "The effect of federal research funding on formation of university-firm biopharmaceutical alliances," The Journal of Technology Transfer, Springer, vol. 40(5), pages 859-876, October.

    Cited by:

    1. Jason Coupet & Yuhao Ba, 2022. "Benchmarking university technology transfer performance with external research funding: a stochastic frontier analysis," The Journal of Technology Transfer, Springer, vol. 47(2), pages 605-620, April.
    2. Zhou Mo & Zhang Yujie & Lei Jiasu & Tan Xiaowen, 2022. "Early firm engagement, government research funding, and the privatization of public knowledge," Scientometrics, Springer;Akadémiai Kiadó, vol. 127(8), pages 4797-4826, August.
    3. Rojas, Mariana Giovanna Andrade & Solis, Edgar Rogelio Ramirez & Zhu, John JianJun, 2018. "Innovation and network multiplexity: R&D and the concurrent effects of two collaboration networks in an emerging economy," Research Policy, Elsevier, vol. 47(6), pages 1111-1124.
    4. Byeongwoo Kang & Kazuyuki Motohashi, 2020. "Academic contribution to industrial innovation by funding type," Scientometrics, Springer;Akadémiai Kiadó, vol. 124(1), pages 169-193, July.

  16. Margaret E. Blume-Kohout & Krishna B. Kumar & Neeraj Sood, 2015. "University R&D Funding Strategies in a Changing Federal Funding Environment," Science and Public Policy, Oxford University Press, vol. 42(3), pages 355-368.

    Cited by:

    1. Rosenbloom, Joshua L. & Ginther, Donna K., 2016. "Show me the Money: Federal R&D Support for Academic Chemistry, 1990–2009," ISU General Staff Papers 201612290800001018, Iowa State University, Department of Economics.
    2. Annita Nugent & Ho Fai Chan & Uwe Dulleck, 2019. "Government Funding of University-Industry Collaboration: Exploring the Impact of Targeted Funding on University Patent Activity," CESifo Working Paper Series 8032, CESifo.
    3. Paige Clayton & Maryann Feldman & Benjamin Montmartin, 2019. "Funding Emerging Ecosystems," GREDEG Working Papers 2019-25, Groupe de REcherche en Droit, Economie, Gestion (GREDEG CNRS), Université Côte d'Azur, France.
    4. Blume-Kohout, Margaret E. & Adhikari, Dadhi, 2016. "Training the scientific workforce: Does funding mechanism matter?," Research Policy, Elsevier, vol. 45(6), pages 1291-1303.
    5. Mikko Packalen & Jay Bhattacharya, 2018. "Does the NIH Fund Edge Science?," NBER Working Papers 24860, National Bureau of Economic Research, Inc.

  17. Neeraj Sood & Zachary Wagner & Yanyu Wu, 2015. "The Impact of Insurance on HIV Testing," American Journal of Health Economics, MIT Press, vol. 1(4), pages 515-536, Fall.

    Cited by:

    1. Friedman, Willa Helterline, 2018. "Antiretroviral drug access and behavior change," Journal of Development Economics, Elsevier, vol. 135(C), pages 392-411.
    2. Aparna Soni, 2020. "The effects of public health insurance on health behaviors: Evidence from the fifth year of Medicaid expansion," Health Economics, John Wiley & Sons, Ltd., vol. 29(12), pages 1586-1605, December.

  18. Étienne Gaudette & Dana Goldman & Andrew Messali & Neeraj Sood, 2015. "Do Statins Reduce the Health and Health Care Costs of Obesity?," PharmacoEconomics, Springer, vol. 33(7), pages 723-734, July.

    Cited by:

    1. Afschin Gandjour, 2016. "Comment on: “The Role of Chronic Disease, Obesity, and Improved Treatment and Detection in Accounting for the Rise in Healthcare Spending Between 1987 and 2011”," Applied Health Economics and Health Policy, Springer, vol. 14(2), pages 241-241, April.
    2. David B Agus & Étienne Gaudette & Dana P Goldman & Andrew Messali, 2016. "The Long-Term Benefits of Increased Aspirin Use by At-Risk Americans Aged 50 and Older," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-12, November.
    3. Christian Frois & Pierre-Yves Cremieux, 2015. "For a Step Change to Curb the Obesity Epidemic," PharmacoEconomics, Springer, vol. 33(7), pages 613-617, July.
    4. Étienne Gaudette & Gwyn C. Pauley & Julie Zissimopoulos, 2016. "Long-term Individual and Population Consequences of Early-life Access to Health Insurance," Working Papers wp355, University of Michigan, Michigan Retirement Research Center.

  19. Huckfeldt, Peter J. & Sood, Neeraj & Escarce, José J. & Grabowski, David C. & Newhouse, Joseph P., 2014. "Effects of Medicare payment reform: Evidence from the home health interim and prospective payment systems," Journal of Health Economics, Elsevier, vol. 34(C), pages 1-18.
    See citations under working paper version above.
  20. Delavande, Adeline & Sampaio, Mafalda & Sood, Neeraj, 2014. "HIV-related social intolerance and risky sexual behavior in a high HIV prevalence environment," Social Science & Medicine, Elsevier, vol. 111(C), pages 84-93.

    Cited by:

    1. Cort, David A. & Reynolds, Kathryn & Chakraborty, Debadatta, 2023. "HIV stigma beliefs and unprotected sex among teenagers and young adults in sub-Saharan Africa: The moderating role of mass media exposure," Social Science & Medicine, Elsevier, vol. 317(C).
    2. Dean Yang & James Allen IV & Arlete Mahumane & James Riddell IV & Hang Yu, 2021. "Knowledge, Stigma, and HIV Testing: An Analysis of a Widespread HIV/AIDS Program," NBER Working Papers 28716, National Bureau of Economic Research, Inc.
    3. Tsai, Alexander C. & Venkataramani, Atheendar S., 2015. "The causal effect of education on HIV stigma in Uganda: Evidence from a natural experiment," Social Science & Medicine, Elsevier, vol. 142(C), pages 37-46.

  21. Sood, Neeraj & Huckfeldt, Peter J. & Grabowski, David C. & Newhouse, Joseph P. & Escarce, José J., 2013. "The effect of prospective payment on admission and treatment policy: Evidence from inpatient rehabilitation facilities," Journal of Health Economics, Elsevier, vol. 32(5), pages 965-979.
    See citations under working paper version above.
  22. Blume-Kohout, Margaret E. & Sood, Neeraj, 2013. "Market size and innovation: Effects of Medicare Part D on pharmaceutical research and development," Journal of Public Economics, Elsevier, vol. 97(C), pages 327-336.

    Cited by:

    1. Lakdawalla, Darius & Sood, Neeraj & Gu, Qian, 2013. "Pharmaceutical advertising and Medicare Part D," Journal of Health Economics, Elsevier, vol. 32(6), pages 1356-1367.
    2. Volker Grossmann, 2011. "Do Cost-sharing and Entry Deregulation Curb Pharmaceutical Innovation?," CESifo Working Paper Series 3439, CESifo.
    3. Hermosilla, Manuel & Wu, Yufei, 2018. "Market size and innovation: The intermediary role of technology licensing," Research Policy, Elsevier, vol. 47(5), pages 980-991.
    4. Chorniy, Anna & Bailey, James & Maloney, Michael & Civan, Abdulkadir, 2019. "Regulatory Review Time and Pharmaceutical R&D," Working Papers 06923, George Mason University, Mercatus Center.
    5. Massimo FLORIO, 2020. "Biomed Europa: after the coronavirus, a public infrastructure to overcome the pharmaceutical oligopoly," CIRIEC Working Papers 2008, CIRIEC - Université de Liège.
    6. Tianyan Hu & Sandra L. Decker & Shin-Yi Chou, 2014. "The Impact of Health Insurance Expansion on Physician Treatment Choice: Medicare Part D and Physician Prescribing," NBER Working Papers 20708, National Bureau of Economic Research, Inc.
    7. Arzi Adbi & Chirantan Chatterjee & Matej Drev & Anant Mishra, 2019. "When the Big One Came: A Natural Experiment on Demand Shock and Market Structure in India's Influenza Vaccine Markets," Production and Operations Management, Production and Operations Management Society, vol. 28(4), pages 810-832, April.
    8. Shao, Chuanlin & Tao, Yunqing & Chen, Dong & Ye, Yongwei, 2023. "Curse or blessing: National industrial investment fund and corporate R&D in China," Finance Research Letters, Elsevier, vol. 54(C).
    9. Hermosilla, Manuel, 2024. "Regulating ethical experimentation: Impacts of the breakthrough therapy designation on drug R&D," Journal of Health Economics, Elsevier, vol. 94(C).
    10. Jeffrey P. Clemens & Morten Olsen, 2021. "Medicare and the Rise of American Medical Patenting: The Economics of User-Driven Innovation," CESifo Working Paper Series 9008, CESifo.
    11. Gamba, Simona & Magazzini, Laura & Pertile, Paolo, 2021. "R&D and market size: Who benefits from orphan drug legislation?," Journal of Health Economics, Elsevier, vol. 80(C).
    12. Dubois, Pierre & de Mouzon, Olivier & Scott Morton, Fiona & Seabright, Paul, 2011. "Market Size and Pharmaceutical Innovation," IDEI Working Papers 670, Institut d'Économie Industrielle (IDEI), Toulouse, revised Mar 2014.
    13. Mayank Aggarwal & Anindya Chakrabarti & Chirantan Chatterjee & Matthew J. Higgins, 2021. "Research and Market Structure: Evidence from an Antibiotic-Resistant Pathogenic Outbreak," NBER Working Papers 28840, National Bureau of Economic Research, Inc.
    14. Dubois, Pierre & Gandhi, Ashvin & Vasserman, Shoshana, 2022. "Bargaining and International Reference Pricing in the Pharmaceutical Industry," TSE Working Papers 22-1338, Toulouse School of Economics (TSE).
    15. Ruchir Agarwal & Patrick Gaulé, 2021. "What Drives Innovation? Lessons from COVID-19 R&D," IMF Working Papers 2021/048, International Monetary Fund.
    16. Jeffrey Clemens & Joshua D. Gottlieb, 2013. "In the Shadow of a Giant: Medicare's Influence on Private Physician Payments," NBER Working Papers 19503, National Bureau of Economic Research, Inc.
    17. Blankart, Katharina & Lichtenberg, Frank R., 2022. "The effects of off-label drug use on disability and medical expenditure," Ruhr Economic Papers 969, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    18. David Besanko & David Dranove & Craig Garthwaite, 2016. "Insurance and the High Prices of Pharmaceuticals," NBER Working Papers 22353, National Bureau of Economic Research, Inc.
    19. Dranove, David & Garthwaite, Craig & Heard, Christopher & Wu, Bingxiao, 2022. "The economics of medical procedure innovation," Journal of Health Economics, Elsevier, vol. 81(C).
    20. Nicholas Bagley & Benjamin Berger & Amitabh Chandra & Craig Garthwaite & Ariel D. Stern, 2018. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century," NBER Chapters, in: Innovation Policy and the Economy, Volume 19, pages 97-137, National Bureau of Economic Research, Inc.
    21. Colleen Carey, 2017. "Technological Change and Risk Adjustment: Benefit Design Incentives in Medicare Part D," American Economic Journal: Economic Policy, American Economic Association, vol. 9(1), pages 38-73, February.
    22. Kevin A. Bryan & Heidi L. Williams, 2021. "Innovation: Market Failures and Public Policies," NBER Working Papers 29173, National Bureau of Economic Research, Inc.
    23. Giammario Impullitti & Richard Kneller & Danny McGowan, 2020. "Demand‐Driven Technical Change and Productivity Growth: Theory and Evidence FROM the Energy Policy Act," Journal of Industrial Economics, Wiley Blackwell, vol. 68(2), pages 328-363, June.
    24. Tianyan Hu & Sandra L. Decker & Shin-Yi Chou, 2017. "The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing," International Journal of Health Economics and Management, Springer, vol. 17(3), pages 333-358, September.
    25. Alpert, Abby & Lakdawalla, Darius & Sood, Neeraj, 2023. "Prescription drug advertising and drug utilization: The role of Medicare Part D," Journal of Public Economics, Elsevier, vol. 221(C).
    26. Jeffrey Clemens & Parker Rogers, 2020. "Demand Shocks, Procurement Policies, and the Nature of Medical Innovation: Evidence from Wartime Prosthetic Device Patents," NBER Working Papers 26679, National Bureau of Economic Research, Inc.
    27. Caroline Savage Bennette & Anirban Basu & Scott D. Ramsey & Zachary Helms & Peter B. Bach, 2019. "Health Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion," American Journal of Health Economics, MIT Press, vol. 5(3), pages 360-375, Summer.
    28. David B. Ridley & Chung-Ying Lee, 2020. "Does Medicare Reimbursement Drive Up Drug Launch Prices?," The Review of Economics and Statistics, MIT Press, vol. 102(5), pages 980-993, December.
    29. Kalcheva, Ivalina & McLemore, Ping & Pant, Shagun, 2018. "Innovation: The interplay between demand-side shock and supply-side environment," Research Policy, Elsevier, vol. 47(2), pages 440-461.
    30. Dubois, Pierre & Majewska, Gosia, 2022. "Mergers and Advertising in the Pharmaceutical Industry," TSE Working Papers 22-1380, Toulouse School of Economics (TSE).
    31. David Dranove & Craig Garthwaite & Manuel Hermosilla, 2014. "Pharmaceutical Profits and the Social Value of Innovation," NBER Working Papers 20212, National Bureau of Economic Research, Inc.
    32. Xuemeng Guo & Ke Guo & Hanzhong Zheng, 2023. "Industrial Agglomeration and Enterprise Innovation Sustainability: Empirical Evidence from the Chinese A-Share Market," Sustainability, MDPI, vol. 15(15), pages 1-26, July.
    33. Joshua L. Krieger & Danielle Li & Dimitris Papanikolaou, 2018. "Missing Novelty in Drug Development," NBER Working Papers 24595, National Bureau of Economic Research, Inc.
    34. Heidi L. Williams, 2015. "Intellectual Property Rights and Innovation: Evidence from Health Care Markets," NBER Working Papers 21246, National Bureau of Economic Research, Inc.
    35. Geng, Hao & Shi, Ce Matthew, 2024. "Health policy, price regulation, and innovation: Evidence from China’s vaccine industry," Journal of Development Economics, Elsevier, vol. 167(C).
    36. Gentilini, Arianna & Miraldo, Marisa, 2023. "The role of patient organisations in research and development: Evidence from rare diseases," Social Science & Medicine, Elsevier, vol. 338(C).
    37. Anna Chorniy & James Bailey & Abdulkadir Civan & Michael Maloney, 2021. "Regulatory review time and pharmaceutical research and development," Health Economics, John Wiley & Sons, Ltd., vol. 30(1), pages 113-128, January.
    38. Higgins, Matthew J. & Yan, Xin & Chatterjee, Chirantan, 2021. "Unpacking the effects of adverse regulatory events: Evidence from pharmaceutical relabeling," Research Policy, Elsevier, vol. 50(1).
    39. Matthew T. Knowles, 2022. "How access to addictive drugs affects the supply of substance abuse treatment: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 31(8), pages 1649-1675, August.
    40. Bhaven Sampat, 2022. "Second World War and the direction of medical innovation," WIPO Economic Research Working Papers 70, World Intellectual Property Organization - Economics and Statistics Division.
    41. Jan Malek & Melissa Newham & Jo Seldeslachts & Reinhilde Veugelers, 2024. "Acquiring R&D Projects: Who, When, and What? Evidence from Antidiabetic Drug Development," Discussion Papers of DIW Berlin 2073, DIW Berlin, German Institute for Economic Research.
    42. Zhang, Xuan & Nie, Huihua, 2021. "Public health insurance and pharmaceutical innovation: Evidence from China," Journal of Development Economics, Elsevier, vol. 148(C).
    43. Sanzenbacher, Geoffrey T. & Wettstein, Gal, 2020. "Drug insurance and the strategic behavior of drug manufacturers: Evergreening and generic entry after Medicare Part D," Journal of Health Economics, Elsevier, vol. 72(C).
    44. Eric Helland & Seth A. Seabury, 2016. "Are Settlements in Patent Litigation Collusive? Evidence from Paragraph IV Challenges," NBER Working Papers 22194, National Bureau of Economic Research, Inc.
    45. Mark Pauly & Kyle Myers, 2016. "A Ricardian-Demand Explanation for Changing Pharmaceutical R&D Productivity," NBER Working Papers 22720, National Bureau of Economic Research, Inc.
    46. Jiafeng Gu, 2021. "Spatial Dynamics between Firm Sales and Environmental Responsibility: The Mediating Role of Corporate Innovation," Sustainability, MDPI, vol. 13(4), pages 1-18, February.
    47. Iizuka, Toshiaki & Uchida, Gyo, 2017. "Promoting innovation in small markets: Evidence from the market for rare and intractable diseases," Journal of Health Economics, Elsevier, vol. 54(C), pages 56-65.
    48. John A. Romley & Neeraj Sood, 2013. "Identifying the Health Production Function: The Case of Hospitals," NBER Working Papers 19490, National Bureau of Economic Research, Inc.
    49. Whaley, Christopher M. & Brown, Timothy T., 2018. "Firm responses to targeted consumer incentives: Evidence from reference pricing for surgical services," Journal of Health Economics, Elsevier, vol. 61(C), pages 111-133.
    50. Robert Nathenson & Michael R. Richards, 2018. "Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws," International Journal of Health Economics and Management, Springer, vol. 18(3), pages 321-336, September.
    51. Besanko, David & Dranove, David & Garthwaite, Craig, 2020. "Insurance access and demand response: Pricing and welfare implications," Journal of Health Economics, Elsevier, vol. 73(C).
    52. Andreas Beerli & Franziska J. Weiss & Fabrizio Zilibotti, 2018. "Demand forces of technical change: evidence from the Chinese manufacturing industry," ECON - Working Papers 277, Department of Economics - University of Zurich.
    53. Samandar Ali Eshtehardi, Mojgan & Bagheri, Seyed Kamran & Di Minin, Alberto, 2017. "Regional innovative behavior: Evidence from Iran," Technological Forecasting and Social Change, Elsevier, vol. 122(C), pages 128-138.
    54. Volker Grossmann, 2021. "Medical Innovations and Ageing: A Health Economics Perspective," CESifo Working Paper Series 9387, CESifo.
    55. Galasso, Alberto & Luo, Hong, 2016. "Tort Reform and Innovation," CEPR Discussion Papers 11358, C.E.P.R. Discussion Papers.
    56. Darius Lakdawalla & Anup Malani & Julian Reif, 2015. "The Insurance Value of Medical Innovation," NBER Working Papers 21015, National Bureau of Economic Research, Inc.
    57. Matteo Alvisi & Emanuela Carbonara, 2020. "Cocktails done right: price competition and welfare when substitutes become complements," Journal of Economics, Springer, vol. 131(1), pages 1-38, September.
    58. Douglas Barthold, 2014. "The Effects of Prescription Drug Cost Sharing: Evidence from the Medicare Modernization Act," Working Papers 14C001, Canadian Centre for Health Economics, revised Nov 2014.
    59. Pourya Darnihamedani & Joern Hendrich Block & Jolanda Hessels & Aram Simonyan, 2015. "Start-up Costs, Taxes and Innovative Entrepreneurship," Tinbergen Institute Discussion Papers 15-013/VII, Tinbergen Institute.
    60. David Dranove & Craig Garthwaite & Manuel I. Hermosilla, 2020. "Expected Profits and The Scientific Novelty of Innovation," NBER Working Papers 27093, National Bureau of Economic Research, Inc.
    61. Beth Woods & James Lomas & Mark Sculpher & Helen Weatherly & Karl Claxton, 2024. "Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required," Health Economics, John Wiley & Sons, Ltd., vol. 33(4), pages 804-819, April.
    62. Leila Agha & Soomi Kim & Danielle Li, 2020. "Insurance Design and Pharmaceutical Innovation," NBER Working Papers 27563, National Bureau of Economic Research, Inc.
    63. Branstetter, Lee G. & Kwon, Namho, 2018. "South Korea's transition from imitator to innovator: The role of external demand shocks," Journal of the Japanese and International Economies, Elsevier, vol. 49(C), pages 28-42.
    64. Christopher P. Adams, 2021. "CBO's Simulation Model of New Drug Development: Working Paper 2021-09," Working Papers 57010, Congressional Budget Office.
    65. Shi-jie Jiang & Lilin Wang & Feiyun Xiang, 2023. "The Effect of Agriculture Insurance on Agricultural Carbon Emissions in China: The Mediation Role of Low-Carbon Technology Innovation," Sustainability, MDPI, vol. 15(5), pages 1-20, March.
    66. Federico Nutarelli & Massimo Riccaboni & Andrea Morescalchi, 2021. "Product recalls, market size and innovation in the pharmaceutical industry," Papers 2111.15389, arXiv.org.
    67. Alberto Galasso & Hong Luo, 2016. "Tort Reform and Innovation," NBER Working Papers 22712, National Bureau of Economic Research, Inc.
    68. Caroline S. Bennette & Anirban Basu & Scott D. Ramsey & Zachary Helms & Peter B. Bach, 2017. "Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion," NBER Working Papers 23842, National Bureau of Economic Research, Inc.
    69. Jillian Chown & David Dranove & Craig Garthwaite & Jordan Keener, 2019. "The Opportunities and Limitations of Monopsony Power in Healthcare: Evidence from the United States and Canada," NBER Working Papers 26122, National Bureau of Economic Research, Inc.

  23. Lakdawalla, Darius & Sood, Neeraj, 2013. "Health insurance as a two-part pricing contract," Journal of Public Economics, Elsevier, vol. 102(C), pages 1-12.
    See citations under working paper version above.
  24. Sood Neeraj & Wagner Zachary & Huckfeldt Peter & Haviland Amelia M., 2013. "Price Shopping in Consumer-Directed Health Plans," Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 35-53, March.

    Cited by:

    1. Amelia M. Haviland & Matthew D. Eisenberg & Ateev Mehrotra & Peter J. Huckfeldt & Neeraj Sood, 2015. "Do “Consumer-Directed” Health Plans Bend the Cost Curve Over Time?," NBER Working Papers 21031, National Bureau of Economic Research, Inc.
    2. Ackley, Calvin A., 2022. "Tiered cost sharing and health care demand," Journal of Health Economics, Elsevier, vol. 85(C).
    3. Whaley, Christopher M., 2019. "Provider responses to online price transparency," Journal of Health Economics, Elsevier, vol. 66(C), pages 241-259.
    4. Eisenberg, Matthew D. & Haviland, Amelia M. & Mehrotra, Ateev & Huckfeldt, Peter J. & Sood, Neeraj, 2017. "The long term effects of “Consumer-Directed” health plans on preventive care use," Journal of Health Economics, Elsevier, vol. 55(C), pages 61-75.
    5. Rabideau, Brendan & Eisenberg, Matthew D. & Reid, Rachel & Sood, Neeraj, 2021. "Effects of employer-offered high-deductible plans on low-value spending in the privately insured population," Journal of Health Economics, Elsevier, vol. 76(C).
    6. Whaley, Christopher M. & Brown, Timothy T., 2018. "Firm responses to targeted consumer incentives: Evidence from reference pricing for surgical services," Journal of Health Economics, Elsevier, vol. 61(C), pages 111-133.

  25. Sood Neeraj & Philipson Tomas J. & Huckfeldt Peter, 2013. "Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors," Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 101-122, April.

    Cited by:

    1. Tomas J. Philipson, 2018. "The Economic Value and Pricing of Personalized Medicine," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 9-19, National Bureau of Economic Research, Inc.

  26. Goldman Dana P. & Gupta Charu & Vasudeva Eshan & Trakas Kostas & Riley Ralph & Lakdawalla Darius & Agus David & Sood Neeraj & Jena Anupam B. & Philipson Tomas J., 2013. "The Value of Diagnostic Testing in Personalized Medicine," Forum for Health Economics & Policy, De Gruyter, vol. 16(2), pages 87-99, September.

    Cited by:

    1. Ernst R. Berndt & Dana P. Goldman & John W. Rowe, 2018. "Introduction to "Economic Dimensions of Personalized and Precision Medicine"," NBER Chapters, in: Economic Dimensions of Personalized and Precision Medicine, pages 1-7, National Bureau of Economic Research, Inc.
    2. Manuel I. Hermosilla & Jorge A. Lemus, 2017. "Therapeutic Translation of Genomic Science: Opportunities and limitations of GWAS," NBER Working Papers 23989, National Bureau of Economic Research, Inc.

  27. Lakdawalla, Darius & Sood, Neeraj & Gu, Qian, 2013. "Pharmaceutical advertising and Medicare Part D," Journal of Health Economics, Elsevier, vol. 32(6), pages 1356-1367.

    Cited by:

    1. Herr, Annika & Suppliet, Moritz, 2012. "Pharmaceutical prices under regulation: Tiered co-payments and reference pricing in Germany," DICE Discussion Papers 48, Heinrich Heine University Düsseldorf, Düsseldorf Institute for Competition Economics (DICE).
    2. Suppliet, Moritz, 2017. "Umbrella Branding in Pharmaceutical Markets," Discussion Paper 2017-034, Tilburg University, Tilburg Law and Economic Center.
    3. Tianyan Hu & Sandra L. Decker & Shin-Yi Chou, 2017. "The impact of health insurance expansion on physician treatment choice: Medicare Part D and physician prescribing," International Journal of Health Economics and Management, Springer, vol. 17(3), pages 333-358, September.
    4. Alpert, Abby & Lakdawalla, Darius & Sood, Neeraj, 2023. "Prescription drug advertising and drug utilization: The role of Medicare Part D," Journal of Public Economics, Elsevier, vol. 221(C).
    5. Dubois, Pierre & Majewska, Gosia, 2022. "Mergers and Advertising in the Pharmaceutical Industry," TSE Working Papers 22-1380, Toulouse School of Economics (TSE).
    6. Thuy D. Nguyen & W. David Bradford & Kosali I. Simon, 2019. "How do Opioid Prescribing Restrictions Affect Pharmaceutical Promotion? Lessons from the Mandatory Access Prescription Drug Monitoring Programs," NBER Working Papers 26356, National Bureau of Economic Research, Inc.
    7. Lawler, Emily C. & Skira, Meghan M., 2022. "Information shocks and pharmaceutical firms’ marketing efforts: Evidence from the Chantix black box warning removal," Journal of Health Economics, Elsevier, vol. 81(C).
    8. Eisenberg, Matthew D. & Avery, Rosemary J. & Cantor, Jonathan H., 2017. "Vitamin panacea: Is advertising fueling demand for products with uncertain scientific benefit?," Journal of Health Economics, Elsevier, vol. 55(C), pages 30-44.
    9. Suppliet, Moritz & Herr, Annika, 2016. "Cost-Sharing and Drug Pricing Strategies : Introducing Tiered Co-Payments in Reference Price Markets," Other publications TiSEM 6430293b-fde9-4f91-ab35-3, Tilburg University, School of Economics and Management.
    10. Robert Nathenson & Michael R. Richards, 2018. "Do coverage mandates affect direct-to-consumer advertising for pharmaceuticals? Evidence from parity laws," International Journal of Health Economics and Management, Springer, vol. 18(3), pages 321-336, September.
    11. Gregory J. Critchley & Gregory S. Zaric, 2019. "The impact of pharmaceutical marketing on market access, treatment coverage, pricing, and social welfare," Health Economics, John Wiley & Sons, Ltd., vol. 28(8), pages 1035-1051, August.
    12. Manuel Hermosilla & Fernanda Gutiérrez-Navratil & Juan Prieto-Rodríguez, 2018. "Can Emerging Markets Tilt Global Product Design? Impacts of Chinese Colorism on Hollywood Castings," Marketing Science, INFORMS, vol. 37(3), pages 356-381, May.
    13. Chatterjee, Chirantan & Joshi, Radhika & Sood, Neeraj & Boregowda, P., 2018. "Government health insurance and spatial peer effects: New evidence from India," Social Science & Medicine, Elsevier, vol. 196(C), pages 131-141.
    14. Caroline S. Bennette & Anirban Basu & Scott D. Ramsey & Zachary Helms & Peter B. Bach, 2017. "Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion," NBER Working Papers 23842, National Bureau of Economic Research, Inc.

  28. Nicholas E Burger & Daniel Kopf & Connor P Spreng & Joanne Yoong & Neeraj Sood, 2012. "Healthy Firms: Constraints to Growth among Private Health Sector Facilities in Ghana and Kenya," PLOS ONE, Public Library of Science, vol. 7(2), pages 1-9, February.

    Cited by:

    1. Stelian STANCU & Eugenia GRECU & Mirela Ionela ACELEANU & Daniela Livia TRAŞCĂ & Claudiu Tiberiu ALBULESCU, 2021. "Does Firm Size Matters for Firm Growth? Evidence from the Romanian Health Sector," Journal for Economic Forecasting, Institute for Economic Forecasting, vol. 0(1), pages 17-31, December.

  29. Haviland Amelia M & Sood Neeraj & McDevitt Roland & Marquis M Susan, 2011. "How Do Consumer-Directed Health Plans Affect Vulnerable Populations?," Forum for Health Economics & Policy, De Gruyter, vol. 14(1), pages 1-25, April.

    Cited by:

    1. Amelia M. Haviland & Matthew D. Eisenberg & Ateev Mehrotra & Peter J. Huckfeldt & Neeraj Sood, 2015. "Do “Consumer-Directed” Health Plans Bend the Cost Curve Over Time?," NBER Working Papers 21031, National Bureau of Economic Research, Inc.
    2. Eisenberg, Matthew D. & Haviland, Amelia M. & Mehrotra, Ateev & Huckfeldt, Peter J. & Sood, Neeraj, 2017. "The long term effects of “Consumer-Directed” health plans on preventive care use," Journal of Health Economics, Elsevier, vol. 55(C), pages 61-75.
    3. Wouters, Olivier J. & Cylus, Jonathan & Yang, Wei & Thomson, Sarah & McKee, Martin, 2016. "Medical savings accounts: assessing their impact on efficiency, equity, and financial protection in health care," LSE Research Online Documents on Economics 65448, London School of Economics and Political Science, LSE Library.
    4. Rabideau, Brendan & Eisenberg, Matthew D. & Reid, Rachel & Sood, Neeraj, 2021. "Effects of employer-offered high-deductible plans on low-value spending in the privately insured population," Journal of Health Economics, Elsevier, vol. 76(C).
    5. Maoyong Fan & Zhen Lei & Gordon Liu, 2016. "Discounting of Medical Savings Accounts," American Journal of Health Economics, MIT Press, vol. 2(2), pages 161-183, Spring.
    6. Hao Yu, 2017. "China’s medical savings accounts: an analysis of the price elasticity of demand for health care," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(6), pages 773-785, July.

  30. Jay Bhattacharya & Neeraj Sood, 2011. "Who Pays for Obesity?," Journal of Economic Perspectives, American Economic Association, vol. 25(1), pages 139-158, Winter.

    Cited by:

    1. Joan Gil & Guillem López Casasnovas & Toni Mora, 2013. "Taxation of unhealthy consumption of food and drinks: An updated literature review," Hacienda Pública Española / Review of Public Economics, IEF, vol. 207(4), pages 119-140, December.
    2. Schnellenbach, Jan, 2012. "Nudges and norms: On the political economy of soft paternalism," European Journal of Political Economy, Elsevier, vol. 28(2), pages 266-277.
    3. Belot, Michèle & James, Jonathan & Nolen, Patrick, 2016. "Incentives and children's dietary choices: A field experiment in primary schools," Journal of Health Economics, Elsevier, vol. 50(C), pages 213-229.
    4. Alberto Gago & Xavier Labandeira & Xiral López Otero, 2014. "A Panorama on Energy Taxes and Green Tax Reforms," Hacienda Pública Española / Review of Public Economics, IEF, vol. 208(1), pages 145-190, March.
    5. Hunt Allcott & Benjamin Lockwood & Dmitry Taubinsky, 2019. "Should We Tax Sugar-Sweetened Beverages? An Overview of Theory and Evidence," NBER Working Papers 25842, National Bureau of Economic Research, Inc.
    6. Parks, Joanna C. & Alston, Julian M. & Okrent, Abigail M., 2013. "The External Health-Care Cost of Obesity in the United States," Working Papers 162526, Robert Mondavi Institute Center for Wine Economics.
    7. Buchmueller, Thomas C. & Johar, Meliyanni, 2015. "Obesity and health expenditures: Evidence from Australia," Economics & Human Biology, Elsevier, vol. 17(C), pages 42-58.
    8. Daniel Mirza & Elena Stancanelli & Thierry Verdier, 2022. "Household Expenditure in the Wake of Terrorism: evidence from high frequency in-home-scanner data," Post-Print halshs-03673160, HAL.
    9. Jayson L. Lusk & Christiane Schroeter, 2013. "When Do Fat Taxes Increase Consumer Welfare? Reply To Neill," Health Economics, John Wiley & Sons, Ltd., vol. 22(10), pages 1284-1286, October.
    10. Lusk, Jayson L., 2013. "Lunch with Pigou: Externalities and the “Hidden” Cost of Food," Agricultural and Resource Economics Review, Cambridge University Press, vol. 42(3), pages 419-435, December.
    11. Hackl, Franz & Halla, Martin & Hummer, Michael & Pruckner, Gerald J., 2012. "The Effectiveness of Health Screening," IZA Discussion Papers 6310, Institute of Labor Economics (IZA).
    12. Rachel Griffith, 2022. "Obesity, Poverty and Public Policy," The Economic Journal, Royal Economic Society, vol. 132(644), pages 1235-1258.
    13. McInerney, Melissa & Meiselbach, Mark K., 2020. "Distributional Effects of Recent Health Insurance Expansions on Weight-Related Outcomes," Economics & Human Biology, Elsevier, vol. 38(C).
    14. Daniel L. Millimet & Ian K. McDonough, 2017. "Dynamic Panel Data Models With Irregular Spacing: With an Application to Early Childhood Development," Journal of Applied Econometrics, John Wiley & Sons, Ltd., vol. 32(4), pages 725-743, June.
    15. Gupta, Shivani & Bansal, Sangeeta, 2021. "Health Implications of Obesity: An Evidence from India," 2021 Conference, August 17-31, 2021, Virtual 315130, International Association of Agricultural Economists.
    16. Hübler, Olaf, 2017. "Health and Body Mass Index: No Simple Relationship," IZA Discussion Papers 10620, Institute of Labor Economics (IZA).
    17. Triaca, Lívia Madeira & dos Santos, Anderson Moreira Aristides & Tejada, Cesar Augusto Oviedo, 2020. "Socioeconomic inequalities in obesity in Brazil," Economics & Human Biology, Elsevier, vol. 39(C).
    18. Ian Irvine & Hai V. Nguyen, 2014. "Is Employment Discrimination Based On Tobacco Use Efficient?," Contemporary Economic Policy, Western Economic Association International, vol. 32(4), pages 752-768, October.
    19. Rachel Griffith & Wenchao (Michelle) Jin & Valérie Lechene, 2022. "The decline of home‐cooked food," Fiscal Studies, John Wiley & Sons, vol. 43(2), pages 105-120, June.
    20. Marco Caliendo & Markus Gehrsitz, 2014. "Obesity and the Labor Market: A Fresh Look at the Weight Penalty," SOEPpapers on Multidisciplinary Panel Data Research 631, DIW Berlin, The German Socio-Economic Panel (SOEP).
    21. Georgia S. Papoutsi & Andreas C. Drichoutis & Rodolfo M. Nayga Jr., 2013. "The Causes Of Childhood Obesity: A Survey," Journal of Economic Surveys, Wiley Blackwell, vol. 27(4), pages 743-767, September.
    22. Schroeter, Christiane & Anders, Sven M., 2013. "Nutrition Label Usage, Diet Health Behavior, and Information Uncertainty," 2013 Annual Meeting, August 4-6, 2013, Washington, D.C. 151214, Agricultural and Applied Economics Association.
    23. Griffith, Rachel & O'Connell, Martin & Smith, Kate & Cherchye, Laurens & De Rock, Bram & Vermeulen, Frederic, 2017. "A new year, a new you? Heterogeneity and self-control in food purchases," CEPR Discussion Papers 12499, C.E.P.R. Discussion Papers.
    24. Jayson L. Lusk, 2017. "Evaluating the Policy Proposals of the Food Movement," Applied Economic Perspectives and Policy, Agricultural and Applied Economics Association, vol. 39(3), pages 387-406.
    25. Ghosh, sudeshna, 2017. "Globalization and Obesity: Asian Experiences of ‘Globesity’," MPRA Paper 94601, University Library of Munich, Germany.
    26. Parks, Joanna C. & Alston, Julian M. & Okrent, Abigail M., 2012. "The Marginal External Cost of Obesity in the United States," 2012 Annual Meeting, August 12-14, 2012, Seattle, Washington 125128, Agricultural and Applied Economics Association.
    27. Paul Koster, 2023. "Urban income inequality and social welfare," Tinbergen Institute Discussion Papers 23-009/VIII, Tinbergen Institute.
    28. Bailey, James, 2013. "Who pays for obesity? Evidence from health insurance benefit mandates," Economics Letters, Elsevier, vol. 121(2), pages 287-289.
    29. Halicioglu, Ferda, 2013. "Dynamics of obesity in Finland," MPRA Paper 48342, University Library of Munich, Germany.
    30. Ian Irvine & William Sims, 2012. "A Taxing Dilemma: Assessing the Impact of Tax and Price Changes on the Tobacco Market," C.D. Howe Institute Commentary, C.D. Howe Institute, issue 350, May.
    31. Olivier Bargain & Jinan Zeidan, 2014. "The Direct Effect of Obesity on Emotional Well-Being: Evidence from Mexico," Working Papers halshs-01024452, HAL.
    32. Jayson L. Lusk & Christiane Schroeter, 2012. "When Do Fat Taxes Increase Consumer Welfare?," Health Economics, John Wiley & Sons, Ltd., vol. 21(11), pages 1367-1374, November.
    33. Charles Courtemanche & Garth Heutel & Patrick McAlvanah, 2015. "Impatience, Incentives and Obesity," Economic Journal, Royal Economic Society, vol. 125(582), pages 1-31, February.
    34. Doble, Brett & Ang Jia Ler, Felicia & Finkelstein, Eric A., 2020. "The effect of implicit and explicit taxes on the purchasing of ‘high-in-calorie’ products: A randomized controlled trial," Economics & Human Biology, Elsevier, vol. 37(C).
    35. Alfredo R. Paloyo & Arndt R. Reichert & Holger Reinermann & Harald Tauchmann, 2014. "The Causal Link Between Financial Incentives And Weight Loss: An Evidence-Based Survey Of The Literature," Journal of Economic Surveys, Wiley Blackwell, vol. 28(3), pages 401-420, July.
    36. Lívia Madeira Triaca & Paulo de Andrade Jacinto & Marco Túlio Aniceto França & César Augusto Oviedo Tejada, 2020. "Does greater unemployment make people thinner in Brazil?," Health Economics, John Wiley & Sons, Ltd., vol. 29(10), pages 1279-1288, October.
    37. Peter J. Huckfeldt & Darius N. Lakdawalla & Tomas J. Philipson, 2012. "Economics of Obesity," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 7, Edward Elgar Publishing.
    38. Hunt Allcott & Benjamin Lockwood & Dmitry Taubinsky, 2019. "Regressive Sin Taxes, With an Application to the Optimal Soda Tax," NBER Working Papers 25841, National Bureau of Economic Research, Inc.
    39. Roy, Manan & Millimet, Daniel L. & Tchernis, Rusty, 2010. "Federal Nutrition Programs and Childhood Obesity: Inside the Black Box," IZA Discussion Papers 5316, Institute of Labor Economics (IZA).
    40. Strupat, Christoph & Farfán, Gabriela & Moritz, Laura & Negre, Mario & Vakis, Renos, 2021. "Obesity and food away from home: What drives the socioeconomic gradient in excess body weight?," Economics & Human Biology, Elsevier, vol. 43(C).
    41. Ian Irvine & William Sims, 2014. "The simple analytics of tobacco taxation with illegal supply," Canadian Journal of Economics/Revue canadienne d'économique, John Wiley & Sons, vol. 47(4), pages 1153-1172, November.
    42. Virat Agrawal & Neeraj Sood & Christopher M. Whaley, 2022. "The Ex-Ante Moral Hazard Effects of COVID-19 Vaccines," NBER Working Papers 30602, National Bureau of Economic Research, Inc.
    43. John Cawley & Chad Meyerhoefer, 2010. "The Medical Care Costs of Obesity: An Instrumental Variables Approach," NBER Working Papers 16467, National Bureau of Economic Research, Inc.
    44. Rachel Griffith & Martin O’Connell & Kate Smith, 2018. "Corrective Taxation and Internalities from Food Consumption," CESifo Economic Studies, CESifo Group, vol. 64(1), pages 1-14.
    45. Paloyo, Alfredo R. & Reichert, Arndt R. & Reuss-Borst, Monika & Tauchmann, Harald, 2015. "Who responds to financial incentives for weight loss? Evidence from a randomized controlled trial," Social Science & Medicine, Elsevier, vol. 145(C), pages 44-52.
    46. Li, Xun & Pan, Wensi & Xu, Gang, 2024. "A “leaner” government? The effect of China's anti-corruption campaign on the body weight and health of public sector employees," Journal of Economic Behavior & Organization, Elsevier, vol. 217(C), pages 141-169.
    47. Hu, Yingyao & Sasaki, Yuya, 2015. "Closed-form estimation of nonparametric models with non-classical measurement errors," Journal of Econometrics, Elsevier, vol. 185(2), pages 392-408.
    48. Salmasi, Luca & Celidoni, Martina, 2017. "Investigating the poverty-obesity paradox in Europe," Economics & Human Biology, Elsevier, vol. 26(C), pages 70-85.
    49. Abraham Abebe Asfaw, 2019. "The effect of prescription drug insurance on health behavior: Evidence from Medicare Part D," Health Economics, John Wiley & Sons, Ltd., vol. 28(3), pages 403-418, March.
    50. Aguilar, Arturo & Gutierrez, Emilio & Seira, Enrique, 2021. "The effectiveness of sin food taxes: Evidence from Mexico," Journal of Health Economics, Elsevier, vol. 77(C).
    51. Augurzky, Boris & Bauer, Thomas K. & Reichert, Arndt R. & Schmidt, Christoph M. & Tauchmann, Harald, 2012. "Does Money Burn Fat? – Evidence from a Randomized Experiment," Ruhr Economic Papers 368, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen.
    52. Shimokawa, Satoru, 2013. "When does dietary knowledge matter to obesity and overweight prevention?," Food Policy, Elsevier, vol. 38(C), pages 35-46.
    53. Cherchye, Laurens & De Rock, Bram & Griffith, Rachel & O’Connell, Martin & Smith, Kate & Vermeulen, Frederic, 2020. "A new year, a new you? Within-individual variation in food purchases," European Economic Review, Elsevier, vol. 127(C).
    54. Étienne Gaudette & Dana Goldman & Andrew Messali & Neeraj Sood, 2015. "Do Statins Reduce the Health and Health Care Costs of Obesity?," PharmacoEconomics, Springer, vol. 33(7), pages 723-734, July.
    55. Ralph Bradley & Colin Baker, 2013. "The Simultaneous Effects of Obesity, Insurance Choice, and Medical Visit Choice on Health Care Costs," NBER Chapters, in: Measuring and Modeling Health Care Costs, pages 211-240, National Bureau of Economic Research, Inc.
    56. Rachel Griffith & Rodrigo Lluberas & Melanie Lührmann, 2016. "Gluttony And Sloth? Calories, Labor Market Activity And The Rise Of Obesity," Journal of the European Economic Association, European Economic Association, vol. 14(6), pages 1253-1286, December.
    57. Cawley, John, 2015. "An economy of scales: A selective review of obesity's economic causes, consequences, and solutions," Journal of Health Economics, Elsevier, vol. 43(C), pages 244-268.
    58. Finkelstein, Eric A. & Zhen, Chen & Bilger, Marcel & Nonnemaker, James & Farooqui, Assad M. & Todd, Jessica E., 2013. "Implications of a sugar-sweetened beverage (SSB) tax when substitutions to non-beverage items are considered," Journal of Health Economics, Elsevier, vol. 32(1), pages 219-239.
    59. Hübler, Olaf, 2017. "Health and weight – gender-specific linkages under heterogeneity, interdependence and resilience factors," Economics & Human Biology, Elsevier, vol. 26(C), pages 96-111.
    60. Rachana Bhatt, 2014. "Timing is Everything: The Impact of School Lunch Length on Children's Body Weight," Southern Economic Journal, John Wiley & Sons, vol. 80(3), pages 656-676, January.
    61. Shivani Gupta & Sangeeta Bansal, "undated". "Overnutrition and Risk of Diabetes: A Micro Data Analysis for India," Centre for International Trade and Development, Jawaharlal Nehru University, New Delhi Discussion Papers 19-04, Centre for International Trade and Development, Jawaharlal Nehru University, New Delhi, India.
    62. Donald L. Alexander & Jon R. Neill, 2017. "Estimating the Corrective Tax for Goods whose Consumption Affects the Consumer’s Health," Atlantic Economic Journal, Springer;International Atlantic Economic Society, vol. 45(1), pages 103-117, March.
    63. S. Sajeesh & Ozgur M. Araz & Terry T.‐K. Huang, 2022. "Market positioning in food industry in response to public health policies," Production and Operations Management, Production and Operations Management Society, vol. 31(7), pages 2962-2981, July.

  31. Neeraj Sood & Nicholas Burger & Joanne Yoong & Dan Kopf & Connor Spreng, 2011. "Firm-Level Perspectives on Public Sector Engagement with Private Healthcare Providers: Survey Evidence from Ghana and Kenya," PLOS ONE, Public Library of Science, vol. 6(11), pages 1-12, November.

    Cited by:

    1. Nicholas E Burger & Daniel Kopf & Connor P Spreng & Joanne Yoong & Neeraj Sood, 2012. "Healthy Firms: Constraints to Growth among Private Health Sector Facilities in Ghana and Kenya," PLOS ONE, Public Library of Science, vol. 7(2), pages 1-9, February.
    2. Gordon Dugle & Stephen Debar Kpinpuo & Benjamin Baisie Ghartey, 2021. "From paper to practice: an exploratory study of policy making and implementation in alternative forms of healthcare public‐private partnership in Ghana," International Journal of Health Planning and Management, Wiley Blackwell, vol. 36(3), pages 866-884, May.

  32. Haviland Amelia M. & Sood Neeraj & McDevitt Roland D. & Marquis M. Susan, 2011. "The Effects of Consumer-Directed Health Plans on Episodes of Health Care," Forum for Health Economics & Policy, De Gruyter, vol. 14(1), pages 1-28, September.

    Cited by:

    1. Sood Neeraj & Wagner Zachary & Huckfeldt Peter & Haviland Amelia M., 2013. "Price Shopping in Consumer-Directed Health Plans," Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 35-53, March.
    2. Ethan M. J. Lieber, 2017. "Does It Pay to Know Prices in Health Care?," American Economic Journal: Economic Policy, American Economic Association, vol. 9(1), pages 154-179, February.

  33. Adeline Delavande & Dana Goldman & Neeraj Sood, 2010. "Criminal Prosecution and Human Immunodeficiency Virus-Related Risky Behavior," Journal of Law and Economics, University of Chicago Press, vol. 53(4), pages 741-782.

    Cited by:

    1. Francis, Andrew M. & Mialon, Hugo M. & Peng, Handie, 2012. "In sickness and in health: Same-sex marriage laws and sexually transmitted infections," Social Science & Medicine, Elsevier, vol. 75(8), pages 1329-1341.
    2. M. V. Lee Badgett & Christopher S. Carpenter & Maxine J. Lee & Dario Sansone, 2024. "A Review of the Economics of Sexual Orientation and Gender Identity," Journal of Economic Literature, American Economic Association, vol. 62(3), pages 948-994, September.

  34. Joanne Yoong & Nicholas Burger & Connor Spreng & Neeraj Sood, 2010. "Private Sector Participation and Health System Performance in Sub-Saharan Africa," PLOS ONE, Public Library of Science, vol. 5(10), pages 1-9, October.

    Cited by:

    1. Idrissa Beogo & Chieh-Yu Liu & Yiing-Jenq Chou & Chuan-Yu Chen & Nicole Huang, 2014. "Health-Care-Seeking Patterns in the Emerging Private Sector in Burkina Faso: A Population-Based Study of Urban Adult Residents in Ouagadougou," PLOS ONE, Public Library of Science, vol. 9(5), pages 1-11, May.
    2. Ole Magnus Theisen & Håvard Strand & Gudrun Østby, 2020. "Ethno-political favouritism in maternal health care service delivery: Micro-level evidence from sub-Saharan Africa, 1981–2014," International Area Studies Review, Center for International Area Studies, Hankuk University of Foreign Studies, vol. 23(1), pages 3-27, March.
    3. Idrissa Beogo & Amadou Darboe & Oluwafunmilade A Adesanya & Bomar Mendez Rojas, 2018. "Choosing between nurse-led and medical doctor-led from private for-profit versus non-for-profit health facilities: A household survey in urban Burkina Faso," PLOS ONE, Public Library of Science, vol. 13(7), pages 1-15, July.
    4. Nicholas E Burger & Daniel Kopf & Connor P Spreng & Joanne Yoong & Neeraj Sood, 2012. "Healthy Firms: Constraints to Growth among Private Health Sector Facilities in Ghana and Kenya," PLOS ONE, Public Library of Science, vol. 7(2), pages 1-9, February.
    5. Neeraj Sood & Nicholas Burger & Joanne Yoong & Dan Kopf & Connor Spreng, 2011. "Firm-Level Perspectives on Public Sector Engagement with Private Healthcare Providers: Survey Evidence from Ghana and Kenya," PLOS ONE, Public Library of Science, vol. 6(11), pages 1-12, November.

  35. Lakdawalla, Darius & Sood, Neeraj, 2009. "Innovation and the welfare effects of public drug insurance," Journal of Public Economics, Elsevier, vol. 93(3-4), pages 541-548, April.

    Cited by:

    1. Lakdawalla, Darius & Sood, Neeraj & Gu, Qian, 2013. "Pharmaceutical advertising and Medicare Part D," Journal of Health Economics, Elsevier, vol. 32(6), pages 1356-1367.
    2. Volker Grossmann, 2011. "Do Cost-sharing and Entry Deregulation Curb Pharmaceutical Innovation?," CESifo Working Paper Series 3439, CESifo.
    3. Patricia M. Danzon & Adrian K. Towse & Jorge Mestre-Ferrandiz, 2012. "Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context," NBER Working Papers 18593, National Bureau of Economic Research, Inc.
    4. Javad Moradpour & Aidan Hollis, 2021. "The economic theory of cost‐effectiveness thresholds in health: Domestic and international implications," Health Economics, John Wiley & Sons, Ltd., vol. 30(5), pages 1139-1151, May.
    5. Boone, J., 2013. "Does the Market Choose Optimal Health Insurance Coverage," Discussion Paper 2013-008, Tilburg University, Tilburg Law and Economic Center.
    6. Hostenkamp, Gisela, 2013. "Do follow-on therapeutic substitutes induce price competition between hospital medicines? Evidence from the Danish hospital sector," Health Policy, Elsevier, vol. 111(1), pages 68-77.
    7. Liran Einav & Amy Finkelstein & Maria Polyakova, 2016. "Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D," NBER Working Papers 22277, National Bureau of Economic Research, Inc.
    8. Jena, Anupam B. & Philipson, Tomas J., 2013. "Endogenous cost-effectiveness analysis and health care technology adoption," Journal of Health Economics, Elsevier, vol. 32(1), pages 172-180.
    9. Ernst R. Berndt & Thomas G. McGuire & Joseph P. Newhouse, 2011. "A Primer on the Economics of Prescription Pharmaceutical Pricing in Health Insurance Markets," NBER Working Papers 16879, National Bureau of Economic Research, Inc.
    10. Hao Zhang & Huimei Hu & Christina Wu & Hai Yu & Hengjin Dong, 2015. "Impact of China's Public Hospital Reform on Healthcare Expenditures and Utilization: A Case Study in ZJ Province," PLOS ONE, Public Library of Science, vol. 10(11), pages 1-19, November.
    11. Rosella Levaggi & Paolo Pertile, 2020. "Which valued‐based price when patients are heterogeneous?," Health Economics, John Wiley & Sons, Ltd., vol. 29(8), pages 923-935, August.
    12. Lakdawalla, Darius & Sood, Neeraj, 2013. "Health insurance as a two-part pricing contract," Journal of Public Economics, Elsevier, vol. 102(C), pages 1-12.
    13. Gilad Sorek & Randolph T. Beard, 2016. "Regulating from the Demand Side: Public Health Insurance with Monopolistically Competitive Providers and Optional Spot Sales," Auburn Economics Working Paper Series auwp2016-06, Department of Economics, Auburn University.
    14. Alice M. Ellyson & Anirban Basu, 2021. "Do pharmaceutical prices rise anticipating branded competition?," Health Economics, John Wiley & Sons, Ltd., vol. 30(5), pages 1070-1081, May.
    15. David B. Ridley & Chung-Ying Lee, 2020. "Does Medicare Reimbursement Drive Up Drug Launch Prices?," The Review of Economics and Statistics, MIT Press, vol. 102(5), pages 980-993, December.
    16. Rosella Levaggi & Michele Moretto & Paolo Pertile, 2013. "The dynamics of pharmaceutical regulation and R&D investments," Working Papers 13/2013, University of Verona, Department of Economics.
    17. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2023. "The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical markets," Journal of Health Economics, Elsevier, vol. 90(C).
    18. Thomas Buchmueller & John C. Ham & Lara D. Shore-Sheppard, 2015. "The Medicaid Program," NBER Working Papers 21425, National Bureau of Economic Research, Inc.
    19. Brekke, Kurt R. & Dalen, Dag Morten & Straume, Odd Rune, 2022. "Paying for pharmaceuticals: uniform pricing versus two-part tariffs," Journal of Health Economics, Elsevier, vol. 83(C).
    20. Glazer, Jacob & McGuire, Thomas G., 2012. "A welfare measure of “offset effects” in health insurance," Journal of Public Economics, Elsevier, vol. 96(5), pages 520-523.
    21. Boone, J., 2013. "Does the Market Choose Optimal Health Insurance Coverage," Other publications TiSEM f7691fbf-f770-4714-b1b4-1, Tilburg University, School of Economics and Management.
    22. Michael D. Frakes & Melissa F. Wasserman, 2020. "Investing in Ex Ante Regulation: Evidence from Pharmaceutical Patent Examination," NBER Working Papers 27579, National Bureau of Economic Research, Inc.
    23. Paul Grootendorst, 2012. "Prescription Drug Insurance and Reimbursement," Chapters, in: Andrew M. Jones (ed.), The Elgar Companion to Health Economics, Second Edition, chapter 11, Edward Elgar Publishing.
    24. Tomas J. Philipson & George Zanjani, 2013. "Economic Analysis of Risk and Uncertainty induced by Health Shocks: A Review and Extension," NBER Working Papers 19005, National Bureau of Economic Research, Inc.
    25. Jakub P. Hlávka & Jeffrey C. Yu & Dana P. Goldman & Darius N. Lakdawalla, 2021. "The economics of alternative payment models for pharmaceuticals," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(4), pages 559-569, June.
    26. Paolo Pertile & Simona Gamba & Martin Forster, 2018. "Free-Riding in Pharmaceutical Price Regulation: Theory and Evidence," Discussion Papers 18/04, Department of Economics, University of York.
    27. Jeffrey Clemens, 2013. "The Effect of U.S. Health Insurance Expansions on Medical Innovation," NBER Working Papers 19761, National Bureau of Economic Research, Inc.
    28. Rosella Levaggi & Paolo Pertile, 2016. "Pricing policies when patients are heterogeneous: a welfare analysis," Working Papers 17/2016, University of Verona, Department of Economics.
    29. Leila Agha & Soomi Kim & Danielle Li, 2020. "Insurance Design and Pharmaceutical Innovation," NBER Working Papers 27563, National Bureau of Economic Research, Inc.
    30. Glazer Jacob & Huskamp Haiden A. & McGuire Thomas G., 2012. "A Prescription for Drug Formulary Evaluation: An Application of Price Indexes," Forum for Health Economics & Policy, De Gruyter, vol. 15(1), pages 1-26, March.
    31. Jurjen Kamphorst & Vladimir Karamychev, 2021. "Going Through The Roof: On Prices for Drugs Sold Through Insurance," Tinbergen Institute Discussion Papers 21-005/VII, Tinbergen Institute.
    32. Alice M. Ellyson & Anirban Basu, 2018. "The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices," NBER Working Papers 24387, National Bureau of Economic Research, Inc.
    33. Sorek Gilad & Randolph Beard T., 2018. "Public Health Insurance with Monopolistically Competitive Providers and Optional Spot Sales," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 18(1), pages 1-10, January.

  36. Bhattacharya, Jay & Goldman, Dana & Sood, Neeraj, 2009. "Market evidence of misperceived mortality risk," Journal of Economic Behavior & Organization, Elsevier, vol. 72(1), pages 451-462, October.

    Cited by:

    1. Carmelo Giaccotto & Joseph Golec & Bryan P. Schmutz, 2017. "Measuring the Performance of the Secondary Market for Life Insurance Policies," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 84(1), pages 127-151, March.
    2. Post, Thomas & Hanewald, Katja, 2010. "Stochastic mortality, subjective survival expectations, and individual saving behavior," SFB 649 Discussion Papers 2010-040, Humboldt University Berlin, Collaborative Research Center 649: Economic Risk.
    3. Bago d'Uva, Teresa & O'Donnell, Owen & van Doorslaer, Eddy, 2020. "Who can predict their own demise? Heterogeneity in the accuracy and value of longevity expectations☆," The Journal of the Economics of Ageing, Elsevier, vol. 17(C).
    4. Innocenti, Stefania & Clark, Gordon L. & McGill, Sarah & Cuñado, Juncal, 2019. "The effect of past health events on intentions to purchase insurance: Evidence from 11 countries," Journal of Economic Psychology, Elsevier, vol. 74(C).

  37. Sood, Neeraj & Buntin, Melinda Beeuwkes & Escarce, José J., 2008. "Does how much and how you pay matter? Evidence from the inpatient rehabilitation care prospective payment system," Journal of Health Economics, Elsevier, vol. 27(4), pages 1046-1059, July.

    Cited by:

    1. Galina Besstremyannaya, 2014. "The adverse effects of value-based purchasing in health care: dynamic quantile regression with endogeneity," Discussion Papers 14-006, Stanford Institute for Economic Policy Research.
    2. Neeraj Sood & Abby Alpert & Kayleigh Barnes & Peter Huckfeldt & Jose Escarce, 2015. "Effects of Payment Reform in More versus Less Competitive Markets," NBER Working Papers 21654, National Bureau of Economic Research, Inc.
    3. Shigeoka, Hitoshi & Fushimi, Kiyohide, 2014. "Supplier-induced demand for newborn treatment: Evidence from Japan," Journal of Health Economics, Elsevier, vol. 35(C), pages 162-178.
    4. Newhouse, Joseph Paul & Huckfeldt, Peter J & Grabowski, David C. & Sood, Neeraj & Escarce, Jose J, 2012. "Effects of Medicare Payment Reform: Evidence from the Home Health Interim and Prospective Payment Systems," Scholarly Articles 8506865, Harvard Kennedy School of Government.
    5. Sood, Neeraj & Huckfeldt, Peter J. & Grabowski, David C. & Newhouse, Joseph P. & Escarce, José J., 2013. "The effect of prospective payment on admission and treatment policy: Evidence from inpatient rehabilitation facilities," Journal of Health Economics, Elsevier, vol. 32(5), pages 965-979.
    6. Galina Besstremyannaya & Dmitry Shapiro, 2012. "Heterogeneous effect of prospective payment system on hospital’s volume and quality," Working Papers w0181, Center for Economic and Financial Research (CEFIR).
    7. R. Verzulli & G. Fiorentini & M. Lippi Bruni & C. Ugolini, 2015. "Price Changes in Regulated Healthcare Markets: Do Public Hospitals Respond and How?," Working Papers wp1041, Dipartimento Scienze Economiche, Universita' di Bologna.
    8. Giuseppe Moscelli & Rowena Jacobs & Nils Gutacker & Maria Jose Aragón & Martin Chalkley & Anne Mason & Jan Böhnke, 2019. "Prospective payment systems and discretionary coding—Evidence from English mental health providers," Health Economics, John Wiley & Sons, Ltd., vol. 28(3), pages 387-402, March.
    9. Galina Besstremyannaya, 2013. "Heterogeneous hospital response to a per diem prospective payment system," Working Papers w0193, New Economic School (NES).
    10. Li‐Lin Liang, 2015. "Do Diagnosis‐Related Group‐Based Payments Incentivise Hospitals to Adjust Output Mix?," Health Economics, John Wiley & Sons, Ltd., vol. 24(4), pages 454-469, April.
    11. He, Daifeng & Mellor, Jennifer M., 2012. "Hospital volume responses to Medicare's Outpatient Prospective Payment System: Evidence from Florida," Journal of Health Economics, Elsevier, vol. 31(5), pages 730-743.
    12. Piia Pekola & Ismo Linnosmaa & Hennamari Mikkola, 2017. "Assessing the effects of price regulation and freedom of choice on quality: evidence from the physiotherapy market," Health Economics Review, Springer, vol. 7(1), pages 1-16, December.
    13. Galina Besstremyannaya, 2016. "Differential Effects of Declining Rates in a Per Diem Payment System," Health Economics, John Wiley & Sons, Ltd., vol. 25(12), pages 1599-1618, December.
    14. Galina Besstremyannaya, 2015. "The adverse effects of incentives regulation in health care: a comparative analysis with the U.S. and Japanese hospital data," Working Papers w0218, Center for Economic and Financial Research (CEFIR).
    15. Galina Besstremyannaya, 2015. "The adverse effects of incentives regulation in health care: a comparative analysis with the U.S. and Japanese hospital data," Working Papers w0218, New Economic School (NES).
    16. Jing Gu & Neeraj Sood & Abe Dunn & John Romley, 2019. "Productivity growth of skilled nursing facilities in the treatment of post-acute-care-intensive conditions," PLOS ONE, Public Library of Science, vol. 14(4), pages 1-14, April.

  38. Sood Neeraj & Ghosh Arkadipta, 2007. "The Short and Long Run Effects of Daylight Saving Time on Fatal Automobile Crashes," The B.E. Journal of Economic Analysis & Policy, De Gruyter, vol. 7(1), pages 1-22, February.

    Cited by:

    1. Giuntella, Osea & Han, Wei & Mazzonna, Fabrizio, 2016. "Circadian Rhythms, Sleep and Cognitive Skills: Evidence from an Unsleeping Giant," IZA Discussion Papers 9774, Institute of Labor Economics (IZA).
    2. Jin, Lawrence & Ziebarth, Nicolas R., 2015. "Does Daylight Saving Time Really Make Us Sick?," IZA Discussion Papers 9088, Institute of Labor Economics (IZA).
    3. Salas Rodriguez, Hugo & Hancevic, Pedro, 2020. "The unexpected effects of daylight-saving time: Traffic accidents in Mexican municipalities," MPRA Paper 101835, University Library of Munich, Germany.
    4. Nicholas Rivers, 2018. "Does Daylight Savings Time Save Energy? Evidence from Ontario," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 70(2), pages 517-543, June.
    5. Gulek, Ahmet, 2024. "Driving while hungry: The effect of fasting on traffic accidents," Journal of Development Economics, Elsevier, vol. 168(C).
    6. Guven, Cahit & Yuan, Haishan & Zhang, Quanda & Aksakalli, Vural, 2021. "When does daylight saving time save electricity? Weather and air-conditioning," Energy Economics, Elsevier, vol. 98(C).
    7. Jin, L. & Ziebarth, N.R., 2015. "Sleep and Human Capital: Evidence from Daylight Saving Time," Health, Econometrics and Data Group (HEDG) Working Papers 15/27, HEDG, c/o Department of Economics, University of York.
    8. Jonathan James, 2023. "Let there be light: Daylight saving time and road traffic collisions," Economic Inquiry, Western Economic Association International, vol. 61(3), pages 523-545, July.
    9. Christian Bünnings & Valentin Schiele, 2021. "Spring Forward, Don't Fall Back: The Effect of Daylight Saving Time on Road Safety," The Review of Economics and Statistics, MIT Press, vol. 103(1), pages 165-176, March.
    10. Kellogg, Ryan & Wolff, Hendrik, 2008. "Daylight time and energy: Evidence from an Australian experiment," Journal of Environmental Economics and Management, Elsevier, vol. 56(3), pages 207-220, November.
    11. Weinhardt, Felix, 2013. "The importance of time zone assignment: evidence from residential electricity consumption," LSE Research Online Documents on Economics 59253, London School of Economics and Political Science, LSE Library.
    12. Arthur Huang & David Levinson, 2008. "The Effects of Daylight Saving Time on Vehicle Crashes in Minnesota," Working Papers 201008, University of Minnesota: Nexus Research Group.
    13. Yi Fan & Diana M. Weinhold, 2022. "Urban noise, sleep disruption and health," Applied Economics, Taylor & Francis Journals, vol. 54(50), pages 5782-5799, October.
    14. Eric Jonathon Osborne‐Christenson, 2022. "Saving light, losing lives: How daylight saving time impacts deaths from suicide and substance abuse," Health Economics, John Wiley & Sons, Ltd., vol. 31(S2), pages 40-68, October.

  39. Arleen Leibowitz & Neeraj Sood, 2007. "Market power and state costs of HIV/AIDS drugs," International Journal of Health Economics and Management, Springer, vol. 7(1), pages 59-71, March.

    Cited by:

    1. Patrick Leoni & Alvaro Sandroni, 2016. "Can patent duration hinder medical innovation," International Journal of Health Economics and Management, Springer, vol. 16(4), pages 397-406, December.

  40. Goldman Dana P & Joyce Geoffrey & Karaca-Mandic Pinar & Sood Neeraj, 2006. "Adverse Selection in Retiree Prescription Drug Plans," Forum for Health Economics & Policy, De Gruyter, vol. 9(1), pages 1-25, December.

    Cited by:

    1. Carey, Colleen, 2021. "Sharing the burden of subsidization: Evidence on pass-through from a subsidy revision in Medicare Part D," Journal of Public Economics, Elsevier, vol. 198(C).
    2. Colleen Carey, 2017. "Technological Change and Risk Adjustment: Benefit Design Incentives in Medicare Part D," American Economic Journal: Economic Policy, American Economic Association, vol. 9(1), pages 38-73, February.
    3. Munkin M & Trivedi P. K, 2009. "Incentives and Selection Effects of Drug Coverage on Total Drug Expenditure: a Finite Mixture Approach," Health, Econometrics and Data Group (HEDG) Working Papers 09/22, HEDG, c/o Department of Economics, University of York.
    4. Murat K. Munkin & Pravin K. Trivedi, 2010. "Disentangling incentives effects of insurance coverage from adverse selection in the case of drug expenditure: a finite mixture approach," Health Economics, John Wiley & Sons, Ltd., vol. 19(9), pages 1093-1108, September.

  41. Darius Lakdawalla & Neeraj Sood & Dana Goldman, 2006. "HIV Breakthroughs and Risky Sexual Behavior," The Quarterly Journal of Economics, President and Fellows of Harvard College, vol. 121(3), pages 1063-1102.
    See citations under working paper version above.
  42. Goldman Dana P & Sood Neeraj & Leibowitz Arleen, 2005. "Wage and Benefit Changes in Response to Rising Health Insurance," Forum for Health Economics & Policy, De Gruyter, vol. 8(1), pages 1-17, January.

    Cited by:

    1. Daron Acemoglu & Andrea Manera & Pascual Restrepo, 2020. "Does the US Tax Code Favor Automation?," NBER Working Papers 27052, National Bureau of Economic Research, Inc.
    2. Jessica Vistnes & Thomas Selden, 2011. "Premium growth and its effect on employer-sponsored insurance," International Journal of Health Economics and Management, Springer, vol. 11(1), pages 55-81, March.
    3. Stéphanie Lluis, 2009. "The Structure of Wages by Firm Size: A Comparison of Canada and the USA," LABOUR, CEIS, vol. 23(2), pages 283-317, June.
    4. Adams, Scott, 2007. "Health insurance market reform and employee compensation: The case of pure community rating in New York," Journal of Public Economics, Elsevier, vol. 91(5-6), pages 1119-1133, June.
    5. DeVaro, Jed & Maxwell, Nan L., 2014. "The elusive wage-benefit trade-off: The case of employer-provided health insurance," International Journal of Industrial Organization, Elsevier, vol. 37(C), pages 23-37.
    6. Nan L. Maxwell, 2008. "Labor Markets And Health Benefits: The Offer And Restrictions On It," Contemporary Economic Policy, Western Economic Association International, vol. 26(1), pages 73-88, January.

  43. Goldman, Dana P. & Sood, Neeraj & Leibowitz, Arleen, 2005. "The reallocation of compensation in response to health insurance premium increases," Economics Letters, Elsevier, vol. 88(2), pages 147-151, August.
    See citations under working paper version above.
  44. Jay Bhattacharya & Dana Goldman & Neeraj Sood, 2004. "Price Regulation in Secondary Insurance Markets," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 71(4), pages 643-675, December.

    Cited by:

    1. Carmelo Giaccotto & Joseph Golec & Bryan P. Schmutz, 2017. "Measuring the Performance of the Secondary Market for Life Insurance Policies," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 84(1), pages 127-151, March.
    2. Nadine Gatzert & Gudrun Hoermann & Hato Schmeiser, 2009. "The Impact of the Secondary Market on Life Insurers’ Surrender Profits," Journal of Risk & Insurance, The American Risk and Insurance Association, vol. 76(4), pages 887-908, December.
    3. Martin Eling & David Pankoke, 2016. "Costs and Benefits of Financial Regulation: An Empirical Assessment for Insurance Companies," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan;The Geneva Association, vol. 41(4), pages 529-554, October.
    4. Mar Jori & Antonio Alegre & Carmen Ribas, 2011. "Deciding the sale of a life policy in the viatical market: Implications on individual welfare," Working Papers in Economics 256, Universitat de Barcelona. Espai de Recerca en Economia.
    5. Nadine Gatzert, 2010. "The Secondary Market for Life Insurance in the United Kingdom, Germany, and the United States: Comparison and Overview," Risk Management and Insurance Review, American Risk and Insurance Association, vol. 13(2), pages 279-301, September.

  45. Lakdawalla, Darius & Sood, Neeraj, 2004. "Social insurance and the design of innovation incentives," Economics Letters, Elsevier, vol. 85(1), pages 57-61, October.

    Cited by:

    1. Emir Emiray & Gabriel Rodriguez, 2003. "Evaluating Time Series Models in Short and Long-Term Forecasting of Canadian Air Passenger Data," Working Papers 0306E, University of Ottawa, Department of Economics.
    2. Shiell, Leslie & Lyssenko, Nikita, 2008. "Computing business-as-usual with a representative agent and a pollution externality," Journal of Economic Dynamics and Control, Elsevier, vol. 32(5), pages 1543-1568, May.
    3. Indira Romero & Gabriel Rodriguez, 2003. "Identifying Permanent and Transitory Components in Latin-American Real Exchange Rates," Working Papers 0308E, University of Ottawa, Department of Economics.
    4. Gamal Atallah, 2002. "Production Technology, Information Technology, and Vertical Integration under Asymmetric Information," CIRANO Working Papers 2002s-32, CIRANO.
    5. Gamal Atallah, 2005. "Partner Selection in R&D Cooperation," Working Papers 0503E, University of Ottawa, Department of Economics.
    6. Gamal Atallah & Marcel Boyer, 2004. "Le financement et l'évaluation de la performance des universités: l'expérience anglaise," Working Papers 0401E, University of Ottawa, Department of Economics.
    7. Gabriel Rodriguez & Yiagadeesen Samy, 2001. "Analyzing the Effects of Labor Standards on U.S. Export Performance: A Time Series Approach With Structural Change," Working Papers 0108E, University of Ottawa, Department of Economics.
    8. Gabriel Rodriguez, 2006. "Stability of Central Bank Preferences, Macroeconomic Shocks, and Efficiency of the Monetary Policy. Empirical Evidence for Canada," Working Papers 0603E, University of Ottawa, Department of Economics.
    9. Gamal Atallah & Gabriel Rodriguez, 2003. "Indirect Patent Citations," Working Papers 0302E, University of Ottawa, Department of Economics.
    10. Gabriel Rodriguez, 2001. "Estimation of the Taylor Rule for Canada Under Multiple Structural Changes," Working Papers 0107E, University of Ottawa, Department of Economics.
    11. Gilles Grenier & Akbar Tavakoli, 2003. "Globalisation and Wage Inequality in the Canadian Manufacturing Sector: A Time Series Analysis," Working Papers 0304E, University of Ottawa, Department of Economics.
    12. Gamal Atallah, 2002. "Information Sharing and the Stability of Cooperation in Research Joint Ventures," Working Papers 0202EClassification-JEL: , University of Ottawa, Department of Economics.
    13. Gamal Atallah, 2004. "The Protection of Innovations," Working Papers 0402E, University of Ottawa, Department of Economics.
    14. Serge Coulombe, 2001. "Should Canadian Regions Adopt the U.S. Dollar?," Working Papers 0106E, University of Ottawa, Department of Economics.
    15. Gabriel Rodriguez & Nicholas Rowe, 2002. "Why U.S. Money does not Cause U.S. Output, but does Cause Hong Kong Output," Working Papers 0201E, University of Ottawa, Department of Economics.
    16. Hui Liu & Gabriel Rodríguez, 2006. "Unit root tests and structural change when the initial observation is drawn from its unconditional distribution," Econometrics Journal, Royal Economic Society, vol. 9(2), pages 225-251, July.
    17. Gabriel Rodriguez, 2003. "Are Canadian Regional Business Cycles All Alike?," Working Papers 0310E, University of Ottawa, Department of Economics.
    18. Vicky Barham & Rose Anne Devlin, 2003. "An Empirical Investigation of Household Dynamics," Working Papers 0303E, University of Ottawa, Department of Economics.
    19. Gamal Atallah & Massoud Khazabi, 2005. "A Model of R&D Capitalization," International Journal of Business and Economics, School of Management Development, Feng Chia University, Taichung, Taiwan, vol. 4(2), pages 107-121, August.
    20. Catherine Deri, 2005. "Understanding the 'Healthy Immigrant Effect' in Canada," Working Papers 0502E, University of Ottawa, Department of Economics.
    21. Barham, Vicky & Devlin, Rose Anne & Yang, Jie, 2009. "A theory of rational marriage and divorce," European Economic Review, Elsevier, vol. 53(1), pages 93-106, January.
    22. Serge Coulombe & Jean-François Tremblay, 2004. "Literacy, Human Capital and Growth," Working Papers 0407E, University of Ottawa, Department of Economics.
    23. Serge Coulombe, 2002. "International Trade, Interprovincial Trade, and Canadian Provincial Growth," Working Papers 0204E, University of Ottawa, Department of Economics.
    24. Leslie M. Shiell, 2004. "Classical (Generalized) Utilitarianism and the Repugnant Conclusion," Working Papers 0404E, University of Ottawa, Department of Economics.
    25. Leslie M. Shiell, 2005. "Population, Impartiality and Sustainability in the Neoclassical Growth Model," Working Papers 0504E, University of Ottawa, Department of Economics.
    26. Gamal Atallah, 2004. "The Allocation of Resources to Cooperative and Noncooperative R&D," CIRANO Working Papers 2004s-01, CIRANO.
    27. Gilles Grenier, 2003. "The Internal Migration of the Immigrant and Native-Born populations in Canada between 1976 and 1996," Working Papers 0301E, University of Ottawa, Department of Economics.
    28. Atallah, Gamal, 2007. "Conditional R&D Subsidies," MPRA Paper 2895, University Library of Munich, Germany.
    29. Gabriel Rodriguez, 2003. "The Role of the Interprovincial Transfers in the B-Convergence Process. Further Empirical Evidence for CanadaAbstract: Based on the approach of Timljonavich and Vogelsang (2002), I present empirical e," Working Papers 0305E, University of Ottawa, Department of Economics.
    30. Hui Liu & Gabriel Rodriguez, 2003. "Human Activities and Global Warming: A Cointegration Analysis," Working Papers 0307E, University of Ottawa, Department of Economics.
    31. Yazid Dissou, 2005. "Output-Based Emissions Allowances and the Equity-Efficiency Trade-off," Working Papers 0505E, University of Ottawa, Department of Economics.
    32. Nguyen Van Quyen & M. H. Zahedi Vafa, 2001. "Endogenous Growth: A Sequential Stochastic Search Model for New Technology," Working Papers 0104E, University of Ottawa, Department of Economics.
    33. Quentin Grafton & Stephen Knowles & P. Dorian Owen, 2001. "Social Divergence and Economic Performance," Working Papers 0103E, University of Ottawa, Department of Economics.
    34. Amornrat Apinunmahakul & Rose Anne Devlin, 2004. "Social/Capital and Private Philanthropy," Working Papers 0406E, University of Ottawa, Department of Economics.
    35. Leslie M. Shiell & Suzanne Loney, 2006. "Global Warming Damages and Canadas Oil Sands," Working Papers 0601E, University of Ottawa, Department of Economics.
    36. Gamal Atallah, 2006. "Entry Deterrence Through Fixed Cost-Reducing R&D," Working Papers 0605E, University of Ottawa, Department of Economics.
    37. Serge Coulombe, 2003. "Human Capital, Urbanization and Canadian Provincial Growth," Regional Studies, Taylor & Francis Journals, vol. 37(3), pages 239-250.
    38. Gilles Grenier, 2001. "En quelle année vaut-il mieux être né? Les revenus des hommes et des femmes au Canada pendant un quart de siècle," Working Papers 0102E, University of Ottawa, Department of Economics.
    39. Kathleen Day & R. Quentin Grafton, 2001. "Economic Growth and the Environment: A Canadian Perspective," Working Papers 0101E, University of Ottawa, Department of Economics.
    40. Gabriel Rodriguez, 2006. "Finite Sample Behaviour of the Level Shift Model using Quasi-Differenced Data," Working Papers 0604E, University of Ottawa, Department of Economics.
    41. Gabriel Rodriguez, 2003. "Identifying Canadian Regional Business Cycles using the Friedmand Plucking Model," Working Papers 0309E, University of Ottawa, Department of Economics.
    42. van Ypersele, Tanguy & Hotte, Louis & Valognes, Fabrice, 2003. "Property Crime with Private Protection: A Market-for-Offenses Approach," CEPR Discussion Papers 3782, C.E.P.R. Discussion Papers.
    43. Michel Beine & Serge Coulombe, 2004. "Economic Integration and Regional Industrial Specialization: Evidence from the Canadian- US FTA Experience," Working Papers 0408E, University of Ottawa, Department of Economics.

  46. Bernard Friedman & Neeraj Sood & Kelly Engstrom & Diane McKenzie, 2004. "New Evidence on Hospital Profitability by Payer Group and the Effects of Payer Generosity," International Journal of Health Economics and Management, Springer, vol. 4(3), pages 231-246, September.

    Cited by:

    1. Charles Hegji, 2007. "A brief look at hospital profits by outpatient services offered," Economics Bulletin, AccessEcon, vol. 9(12), pages 1-10.
    2. Long Mark C & Goldfarb Marsha G. & Goldfarb Robert S, 2008. "Explanations for Persistent Nursing Shortages," Forum for Health Economics & Policy, De Gruyter, vol. 11(2), pages 1-37, November.
    3. He, Daifeng & Mellor, Jennifer M., 2012. "Hospital volume responses to Medicare's Outpatient Prospective Payment System: Evidence from Florida," Journal of Health Economics, Elsevier, vol. 31(5), pages 730-743.
    4. Na-Eun Cho & KiHoon Hong, 2018. "A Kitchen with too Many Cooks: Factors Associated with Hospital Profitability," Sustainability, MDPI, vol. 10(2), pages 1-14, January.

  47. Bhattacharya, Jayanta & Goldman, Dana & Sood, Neeraj, 2003. "The link between public and private insurance and HIV-related mortality," Journal of Health Economics, Elsevier, vol. 22(6), pages 1105-1122, November.
    See citations under working paper version above.
  48. Bhattacharya, Jayanta & Schoenbaum, Michael & Sood, Neeraj, 2002. "Optimal contributions to flexible spending accounts," Economics Letters, Elsevier, vol. 76(1), pages 129-135, June.

    Cited by:

    1. Jessica Leight & Nicholas Wilson, 2020. "Framing Flexible Spending Accounts: A Large‐Scale Field Experiment on Communicating the Return on Medical Savings Accounts," Health Economics, John Wiley & Sons, Ltd., vol. 29(2), pages 195-208, February.
    2. Barton H. Hamilton & James Marton, 2008. "Employee choice of flexible spending account participation and health plan," Health Economics, John Wiley & Sons, Ltd., vol. 17(7), pages 793-813, July.

Chapters

  1. John A. Romley & Abe Dunn & Dana Goldman & Neeraj Sood, 2020. "Quantifying Productivity Growth in the Delivery of Important Episodes of Care within the Medicare Program Using Insurance Claims and Administrative Data," NBER Chapters, in: Big Data for Twenty-First-Century Economic Statistics, pages 297-338, National Bureau of Economic Research, Inc.

    Cited by:

    1. Abe C. Dunn & Lasanthi Fernando & Eli Liebman, 2023. "A Direct Measure of Medical Innovation on Health Care Spending: A Condition-Specific Approach," BEA Papers 0121, Bureau of Economic Analysis.
    2. Dauda, Seidu & Dunn, Abe & Hall, Anne, 2022. "A systematic examination of quality-adjusted price index alternatives for medical care using claims data," Journal of Health Economics, Elsevier, vol. 85(C).

  2. Jay Bhattacharya & M. Kate Bundorf & Noemi Pace & Neeraj Sood, 2011. "Does Health Insurance Make You Fat?," NBER Chapters, in: Economic Aspects of Obesity, pages 35-64, National Bureau of Economic Research, Inc.
    See citations under working paper version above.
  3. Jay Bhattacharya & Neeraj Sood, 2006. "Health Insurance and the Obesity Externality," Advances in Health Economics and Health Services Research, in: The Economics of Obesity, pages 279-318, Emerald Group Publishing Limited.
    See citations under working paper version above.
  4. Dana P. Goldman & Geoffrey Joyce & Pinar Karaca-Mandic & Neeraj Sood, 2006. "Adverse Selection in Retiree Prescription Drug Plans," NBER Chapters, in: Frontiers in Health Policy Research, Volume 9, National Bureau of Economic Research, Inc.
    See citations under working paper version above.
  5. Dana P. Goldman & Neeraj Sood & Arleen Leibowitz, 2005. "Wage and Benefit Changes in Response to Rising Health Insurance," NBER Chapters, in: Frontiers in Health Policy Research, Volume 8, National Bureau of Economic Research, Inc.
    See citations under working paper version above.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.